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ABSTRACT 
RAFAEL JOSE ROJAS: Coordinating the Activation of RhoA by Diverse RhoGEFs: 
SmgGDS and G-alpha-q-Responsive Dbl Family Guanine Nucleotide Exchange Factors 
(Under the direction of John Sondek) 
 
G proteins are molecular switches that fluctuate between on and off states and 
regulate a multitude of essential signaling cascades within the cell.  G proteins implicated in 
signal transduction can be divided into two major groups, the heterotrimeric G proteins and 
the small GTPases, such as Rho.  Rho-related GTPases are activated primarily by guanine 
nucleotide exchange factors (GEFs) of the Dbl family.  Dbl family GEFs are regulated via a 
number of mechanisms and typically function as signaling nodes by coupling several major 
signal transduction cascades.  Additionally, there is a subset of atypical GEFs for Rho 
GTPases that are not related to the conventional Dbl family.  However, the mechanism by 
which atypical GEFs engage Rho GTPases is poorly defined.   
Here we present a study of guanine nucleotide exchange upon the small GTPase Rho 
mediated by two distinct exchange factors, the Dbl family member p63RhoGEF and the atypical GEF 
SmgGDS.  We describe the novel mechanism by which p63RhoGEF is activated by the 
heterotrimeric G protein Gαq to stimulate guanine nucleotide exchange upon the small GTPase Rho.  
Additionally, we demonstrate the GTPase substrate specificity of SmgGDS and describe the 
preliminary crystallization of SmgGDS bound to Rho.  Together, these studies further our knowledge 
of the underlying pathways and mechanisms by which the small GTPase Rho is activated. 
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 CHAPTER 1: INTRODUCTION 
Part 1: G proteins 
G proteins are molecular switches 
Guanine nucleotide binding proteins (G proteins) are a large group of ~100-150 
signaling molecules defined by their ability to bind the guanine nucleotides GDP and GTP 
[1, 2].  G proteins are essential for the regulation of a multitude of diverse physiological 
events and play vital roles in numerous human diseases.  Many of these proteins mediate 
intracellular signal transduction cascades and form critical nodes linking extracellular stimuli 
to downstream physiological effects.  The majority of G proteins can be divided into three 
major superfamilies: (1) the heterotrimeric Gα-subunits, (2) the monomeric “small” GTPases 
of the Ras superfamily, and (3) the elongation factors.  The work presented here will focus on 
Gα-subunits and Ras superfamily members.  Consequently, the elongation factors, which are 
involved in mRNA translation at the ribosome, will not be further discussed.  All G proteins 
act as binary switches and share a universal mechanism for guanine nucleotide binding, GTP 
hydrolysis, and conformational switching and are structurally defined by the existence of a 
core Ras-like domain [2].  Numerous G protein subfamilies can be grouped based on their 
sequence conservation and typically share additional structural elements as insertions to the 
core Ras-like domain. 
Flexible “switch regions” are sensitive to the nucleotide-bound state and engender a 
switch-like capacity by having unique conformations dependent on whether GTP or GDP is 
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bound [2].  While G proteins are typically thought of existing in only two discrete states, a 
GTP-bound “on” state and a GDP-bound “off” state, there are two additional intermediate 
states that are transient in nature.  This arises from an intrinsic capacity to both spontaneously 
exchange guanine nucleotide and hydrolyze the terminal γ-phosphate of GTP, allowing the 
fleeting existence of a nucleotide-free state and transition state of GTP hydrolysis.   
Guanine nucleotide exchange factors (GEFs) are the class of regulatory proteins that 
activate G proteins.  Generally, GEFs function by preferentially interacting with the 
nucleotide-free form of G-proteins, thereby facilitating the release of bound nucleotide.  
Subsequent re-binding of guanine nucleotide promotes the release of the GEF-G protein 
complex.  In a cell, the concentration of GTP greatly exceeds that of GDP, therefore GTP 
replaces GDP; for this reason, GEFs activate G proteins.  A divalent cation, such as Mg2+, is 
utilized by G proteins as a cofactor to offset the negative charge associated with the α- and β-
phosphates of bound GDP/GTP.  Divalent chelators, such as ethylenediamine tetra-acetic 
acid (EDTA) can strip this Mg2+ ion, resulting in a greatly reduced affinity for guanine 
nucleotide and the persistence of a nucleotide-free state.   
Inactivation of GTP-bound G protein occurs via an intrinsic GTP hydrolysis capacity, 
which is greatly enhanced by another class of regulatory proteins known as GTPase 
accelerating proteins (GAPs).  These GAPs generally recognize the fleeting conformation 
that accompanies GTP hydrolysis and stabilizes this transitional intermediate state.  Active, 
GTP-bound G protein can preferentially interact with any number of downstream effector 
molecules further propagating the signaling cascade.  Some G proteins have an additional 
mode of regulation; guanine nucleotide dissociation inhibitors (GDIs) function to bind GDP-
bound G proteins and inhibit spontaneous nucleotide exchange.  Therefore, GDIs prevent the 
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G protein from engaging in the guanine nucleotide exchange cycle and can additionally 
sequester G proteins in an unproductive environment, such as the cytosol.   
 
GPCRs mediate transmembrane signal transduction 
G protein-coupled receptors (GPCRs) are seven transmembrane receptors, which are 
responsive to a wide range of extracellular ligands including: photons, amino acids, peptides 
and polypeptides, purines and nucleotides, biogenic amines, and lipids [3, 4].  These 
extracellular stimuli control such diverse physiological processes as sensory perception, cell 
growth and differentiation, metabolism, and neurotransmission.  GPCRs mediate 
transmembrane signal transduction by acting as GEFs for heterotrimeric Gα-subunits.  
Moreover, GPCRs make up the largest group of transmembrane signaling proteins found on 
the cell surface and one of the largest classes of genes in the human genome [3].  The Gα-
subunit selectivity of GPCRs varies greatly, but is typically promiscuous in nature and should 
be considered on a case-by-case basis [5].   
Activated GPCRs are in turn regulated by G protein-coupled receptor kinases (GRKs) 
and β-arrestins, which function together to desensitize the activated GPCR [6].  GRKs are 
serine/threonine kinases which phosphorylate intracellular regions of activated GPCRs.  This 
phosphorylation event primes the GPCR for β-arrestin binding, which facilitates receptor 
endocytosis, trafficking, and degradation.  More recently, β-arrestins have been implicated as 
multifunctional adaptor/scaffolding proteins which regulate diverse signal transduction 
cascades in their own right [7].  Aberrant signaling of GPCR/heterotrimeric G protein 
signaling contributes significantly to human disease states; over half of all currently marketed 
drugs target GPCRs and alter heterotrimeric G protein signaling.  
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Heterotrimeric G proteins consist of the guanine nucleotide-binding Gα-subunit as 
well as the obligate heterodimer of Gβ bound to Gγ, which is commonly referred to as the 
Gβγ-subunit.  Crystal structures of the various activation states of Gα-subunits have been 
determined [8-12], as has the structure of Gβγ dimeric complexes [13, 14], and the Gαβγ 
heterotrimer [15, 16] providing unprecedented insight into the molecular mechanism of 
conformational switching and binding specificities.  These studies have revealed that in 
addition to the core Ras-like domain found in all G proteins, Gα-subunits also contain a 
conserved all-helical domain which has been implicated in GTP hydrolysis and effector 
binding [1, 17].   
In an inactivated state, the heterotrimer consists of Gα-GDP bound to the Gβγ dimer.  
Within the context of a heterotrimer, the Gβγ-subunit acts as a GDI for the Gα-subunit, by 
preventing the spontaneous exchange of guanine nucleotide.  Upon extracellular stimulation 
of a GPCR, a conformation change within the receptor induces guanine nucleotide exchange 
upon the Gα-subunit.  While the mechanism of GPCR-mediated activation of Gα-subunits 
remains poorly understood, recent structural and biochemical studies have been instrumental 
in furthering our current understanding [18].   
Activation of Gα-subunits results in the dissociation of the heterotrimer into Gα-GTP 
and Gβγ, both of which can go on to interact with downstream effectors molecules and 
mediate independent signaling cascades.  GAPs specific for Gα-subunits typically contain a 
domain termed the regulator of G protein signaling domain (RGS domain) [19].  Structural 
studies have elucidated that RGS domains preferentially bind to a GTP hydrolysis transition 
state [20]; this molecular mechanism of action will be further discussed below.  Inactivated, 
Gα-GDP can then re-associate with Gβγ forming the inactive heterotrimer, thereby 
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completing the guanine nucleotide exchange cycle.  Some Gα-subunits are additionally 
regulated by GDIs which are characterized by the presence of a GoLoco motif [21].  
Heterotrimeric G proteins are localized to the plasma membrane via several post-
translational modifications that serve as hydrophobic tethers.  For example, Gαi family 
members are myristoylated at the N-terminus while all Gα-subunits, with the exception of 
Gαt, are reversibly palmitoylated, at least once, at cysteine residues near the N-terminus [1].  
Additionally, Gβγ dimers are also membrane localized by way of Gγ-subunit isoprenylation; 
a C-terminal CAAX motif allows the covalent coupling of a geranylgeranyl or a farnesyl 
moiety to the C-terminus of the Gγ-subunit. 
The human Gα-subunits comprise four major families: Gαi/o, Gαs, Gα12/13, and 
Gαq/11 (Fig. 1) [5].  Members of the Gαi/o family inhibit several types of adenylyl cyclases 
(ACs), which convert ATP into the second messenger cAMP.  Expression levels of the Gαi/o 
family members are typically high relative to the other Gα-subunits.  Therefore, GPCR-
mediated activation of Gαi/o family members is a major mechanism for releasing Gβγ-
subunits, which go on to regulate signal transduction pathways in their own right, including 
ion channels, ACs, phosphoinositide 3-kinases (PI3-K), and phospholipase C (PLC) 
isoforms.  Gαi/o family members are additionally ADP-ribosylated by pertussis toxin 
generated by Clostridium botulinum, rendering these Gα-subunits inactive.  In contrast to the 
Gαi/o family, the Gαs family functions to stimulate AC, increasing the production of the 
second messenger cAMP, which goes on to activate protein kinase A (PKA).  Gα12/13 
family proteins are upstream activators of the small GTPase RhoA, and will be further 
discussed below.   
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Of particular significance to the work presented here are the Gαq/11 family members, 
which regulate numerous physiological processes, including cell growth, neuronal migration, 
platelet aggregation, actin cytoskeletal dynamics, and smooth muscle cell contraction [22].  
Gαq and Gα11 share 90% sequence identity and are both ubiquitously expressed in many 
tissues types [22].  Moreover, both Gαq and Gα11 share similar signaling properties with 
regards to GPCR selectivity, effector coupling, and regulation by RGS proteins.  Genetic 
analysis also suggests that members of the Gαq/11 family have somewhat redundant 
functions [23, 24].  As a result, Gαq and Gα11 are often described collectively as Gαq/11.   
The other Gαq/11 family members, Gα14 and Gα15/16, are not well characterized.  
However, both are known to activate canonical effectors similarly to Gαq/11.  Gα14 and 
Gα15/16 (Gα15 in mouse, Gα16 in human) share 80% and 57% sequence identity to Gαq, 
respectively [22].  Additionally, Gα14 and Gα15/16 have much more restrictive expression 
patterns compared to Gαq and Gα11; Gα14 is found primarily in spleen, pancreas, kidney, 
liver, and lung, while Gα15/16 is selectively expressed in hematopoietic cells [22].  These 
properties may impart unique signaling characteristics to the Gα14 and Gα15/16 dependent 
upon cell type.  
The classically described effectors for Gαq/11 family proteins are the phospholipase 
C-β isozymes (PLC-β).  PLC-β binds to activated Gαq via a mechanism that remains unclear.  
However, a unique C-terminus within PLC-β, which mediates homodimerization, is 
important for binding activated Gαq [25].  More recently, evidence has shown that the Rho 
subfamily member Rac1 and Gβγ dimers both activate PLC-β [26-29].   
PLC-β functions to cleave the minor membrane phospholipid phosphatidylinositol 
(4,5)-bisphosphate (PI(4,5)P2) into the second messengers diacylglycerol (DAG) and inositol 
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(1,4,5)-trisphosphate (IP3) [27].  DAG remains plasma membrane localized and promotes the 
activation of protein kinase C (PKC) while IP3 is released into the cytosol where it promotes 
the mobilization of intracellular Ca2+ stores by opening Ca2+ channels in the endoplasmic 
reticulum.  PKC and intracellular Ca2+ each regulate important signaling cascades within the 
cell.  PI(4,5)P2 has important signaling properties outside of merely serving as a substrate for 
PLC isozymes.  PI(4,5)P2 can be converted by PI3-K into phosphatidylinositol (3,4,5)-
trisphosphate (PI(3,4,5)P3).  Both PI(4,5)P2 and PI(3,4,5)P3 can interact with a number of 
lipid-binding domains resulting in the recruitment of diverse signaling proteins to discrete 
regions of the plasma membrane and their concomitant activation.  Therefore, PLC-mediated 
depletion of PI(4,5)P2 and PI(3,4,5)P3 at the plasma membrane can additionally have major 
signaling implications.   
 
Rho GTPases regulate the actin cytoskeleton 
The Ras superfamily consists of over 150 members categorized into several 
subfamilies based upon sequence homology comprising the Ras, Rho, Ran, Rab, Arf, and 
Rem/Rad subfamilies [30-33].  These monomeric GTPases of ~21 kDa are essential for a 
variety of biological phenomenon.  In particular, members of the Ras and Rho subfamilies 
are the most extensively studied group of small GTPases and are essential components of the 
mitogenic signal transduction pathway.  Extracellular stimulation of receptor tyrosine 
kinases, GPCRs, or integrins can result in activation of Ras and the prototypical Rho 
subfamily members RhoA, Rac1, and Cdc42 [34, 35].   
Once activated, Ras and Rho GTPases further propagate external signals by activating 
a multitude of downstream effector proteins, resulting in a diversity of cellular responses.  
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Extensive crosstalk exists between the major pathways currently defined for Ras and Rho 
GTPases, adding an additional layer of signaling complexity.  The eponymous member, Ras, 
is the central component and regulator of a critical signaling pathway mediating cell growth 
[32, 33, 36].  Activation of growth factor (GF) receptor tyrosine kinases (RTKs), such as the 
EGF-R, results in the recruitment of the SH2/SH3 adaptor protein Grb2 via an SH2-
phosphotyrosine interaction.  Grb2 subsequently recruits the RasGEF Sos1 to the plasma 
membrane via an SH3-polyproline interaction, resulting in the GTP-loading and activation of 
Ras.  Activated Ras then goes on to activate a number of critical signaling pathways by 
directly engaging various effector proteins, such as RalGDS, PI3-K, and Raf.  In particular, 
activation of Raf regulates a major mitogen-activated protein kinase (MAPK) cascade 
(Raf/MEK/ERK) that controls transcriptional activation of numerous mitogenic genes [32, 
33, 36].  
Activation of Ras and Rho subfamily GTPases is a critical step during tumor 
progression and the acquisition of an invasive and metastatic phenotype [37-41].  These 
proteins are highly oncogenic with over 30% of all human cancers and 90% of pancreatic 
cancers harboring activated Ras mutations [41].  Recent evidence also suggests a vital role 
for Rho subfamily members during transformation and the acquisition of an invasive and 
metastatic phenotype by regulating the actin cytoskeleton [42-45].  Furthermore, GEFs 
specific to Rho GTPases are routinely isolated during oncogenic screens and make up one the 
largest classes of human proto-oncogenes [46, 47].  
The Rho subfamily GTPases are integral regulators of the spatial-temporal 
organization and assembly of the actin cytoskeleton during many dynamic cellular processes 
such as cell division, endocytosis, cell migration, and neuronal guidance [35, 48].  Virtually 
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every eukaryotic genome harbors at least one Rho-like small GTPase, and in the case of 
humans, there are approximately 20 Rho subfamily members [48, 49] (Fig. 2).  The most 
characterized of these are RhoA, Rac1, and Cdc42; singular activation of each produces 
distinct cell morphologies [34, 35, 48, 50] (Fig. 2).  Activation of Rac1 and the close 
isozymes Rac2 and Rac3 (collectively referred to as Rac) result in the formation of thin 
membrane protrusions at the leading edge of a migrating cell, termed lamellipodia, while 
Cdc42 activation results in formation of actin microspike extensions, termed filopodia.  
Activation of RhoA and the close isozymes RhoB and RhoC (collectively referred to as Rho) 
results in the formation of dense actin-rich intracellular mesh-works, termed stress fibers, and 
large integrin-associated adhesion complexes to the extracellular substrata, termed focal 
adhesions.   
In addition to their vital roles as master controllers of the actin cytoskeleton, Rho 
subfamily GTPases are also important regulators of cell growth and apoptosis by modulating 
the activity of downstream gene transcription factors, such as serum response factor (SRF) 
and nuclear factor-κB (NF-κB), and regulating MAPK signaling, such as c-jun N-terminal 
kinase (JNK) [34, 35, 48, 50].  While Rho, Rac, and Cdc42 have been shown to activate SRF 
and NF-κB, the JNK/p38 pathway is regulated primarily by Cdc42 and Rac isozymes [50].  
Given their vital role in regulating cell morphology and cellular growth, it is not surprising 
that aberrant regulation of Rho GTPases are implicated in many disease states and 
developmental abnormalities [38, 41].  The main focus of this study revolves around the Rho 
isozymes in particular, and these will therefore be further discussed below. 
Rho subfamily GTPases are lipid-modified similar to heterotrimeric G proteins, 
rendering them membrane-localized for efficient coupling to upstream activators and 
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downstream effectors.  For example, prenylation of the Rho isozymes imparts unique 
signaling characteristics.  RhoA, RhoB, and RhoC are all similarly post-translationally 
modified by prenylation at the extreme C-terminus via a conserved CAAX motif [51].  
However, the covalently attached group in RhoA and RhoC is invariably a 20-carbon 
geranylgeranyl moiety while RhoB can be modified by either a geranylgeranyl moiety or a 
15-carbon farnesyl moiety.  This imparts a unique sub-cellular distribution; while RhoA and 
RhoC can be found in the cytoplasm and at the plasma membrane, RhoB is found on late 
endosomes and lysosomes [52].  Interestingly, most of the sequence variation between RhoA, 
RhoB, and RhoC is encompassed near the C-terminal polybasic region (PBR).  This C-
terminal region of Rho GTPases is critical for correct subcellular localization to intracellular 
membranes, allowing for distinct regulation by differentially localized GEFs and GAPs and 
in turn activation of distinct effector proteins. 
Numerous effectors for the various Rho GTPases have been described, including 
many kinases and scaffolding proteins, which function in concert to regulate the actin 
cytoskeleton and gene transcription [50].  Of particular significance to this study are the 
canonical effectors of the Rho isozymes.  The two classically described effectors of Rho 
isoforms which are required for stress fiber formation and focal adhesion assembly are: (1) 
the Ser/Thr Rho kinase (ROCK), which phosphorylates and thereby inactivates myosin light 
chain (MLC) phosphatase, leading to actinomyosin assembly and contraction and (2) the 
formin homology family protein mDia which interacts with profilin, a G-actin binding 
protein resulting in increased actin polymerization.  Other less characterized Rho effectors 
include citron kinase, PRK, rhotekin, and PLC-ε [50].   
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With the exception of the poorly characterized RhoB-specific effector p76RBE [53], 
effectors for Rho can typically bind to all three Rho isozymes, albeit with varying affinities.  
For example, RhoC has been shown to more effectively activate ROCK and citron kinase in 
comparison to RhoA and RhoB [50].  Co-localization studies also suggest that PRK1 
specifically associates with RhoB at the endosome.  Signaling differences among the Rho 
isozymes impart unique phenotypic properties to RhoA, RhoB, and RhoC.  For instance, 
RhoA and RhoB, but not RhoC promote cell transformation.  While RhoA has been found to 
be up-regulated in certain cancers, recent studies indicate that RhoC plays a unique and 
critical role during cancer invasion and metastasis [44].  In contrast to RhoA and RhoC, 
RhoB overexpression inhibits cell motility and has decreased levels of expression in certain 
cancers.  Additionally, mounting evidence suggests that RhoB plays a unique role in the 
stress response via pro-apoptotic activity [54].    
 
Dbl family GEFs activate Rho GTPases 
Dbl family GEFs are the major class of exchange factors for Rho GTPases and are 
defined by the presence of Dbl homology domain (DH domain) [55].  This family composed 
of 69 human proteins is named after the founding member Dbl, which was isolated during an 
oncogenic screen in diffuse B-cell lymphoma [56].  Dbl family members are typically multi-
domain containing proteins which functionally couple Rho subfamily activation to various 
other signal transduction cascades (Fig. 3).  As mentioned above, Dbl family GEFs are 
routinely isolated during oncogenic screens and are often found in a truncated form, which 
enhances its capacity to activate Rho subfamily members.  Dbl family GEFs can 
differentially couple to one or more of the 20 Rho GTPases dependent upon specificity 
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restraints; some Dbl family are highly specific for a single GTPase while others are 
promiscuous in nature and activate many Rho GTPases [57].   
The catalytic guanine nucleotide exchange activity of Dbl family GEFs resides 
entirely within the DH domain.  The structural elucidation of several GEF-GTPase 
complexes has revealed a conserved mechanism of Rho GTPase activation [49, 57-60].  The 
DH domain is almost always accompanied by a C-terminal PH domain, together they 
comprise a functional DH-PH cassette.  This exclusive coupling suggests a functional 
necessity for the accompanying PH domain; however, a universal role for the DH-associated 
PH domain has not yet been identified.  The PH domain has long been considered a simple 
membrane targeting device, by virtue of its ability to differentially bind phosphoinositides, 
albeit with weak affinity and low specificity [61].  Interestingly, the single exception to the 
“PH domain always follows a DH domain” rule is Tuba, which has a BAR domain, instead 
of the invariant PH domain [62].  In this instance, it has been speculated that the BAR 
domain can functionally replace the PH domain, due to its membrane-associating capacity 
[55]. 
Aside from its membrane-targeting properties, emerging evidence suggests that PH 
domains may also play important regulatory roles by serving as protein-protein interaction 
modules [63].  The PH domain of non-Dbl family proteins, such as GRK2 [64] and PLC-β 
[28, 29, 65] has been previously characterized for mediating protein-protein interactions.  
Additionally, within the Dbl family the DH-associated PH domains of Dbs (Dbl’s big sister) 
[66], Vav2 [67], Tiam1 (T-cell lymphoma invasion and metastasis factor-1) [67], and 
Scambio [68] have been shown to be effector sites for Ras superfamily GTPases (Table 1).   
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The DH-associated PH domain can also directly modulate the engagement of Rho 
GTPase substrates and assist in guanine nucleotide exchange.  This phenomenon is termed 
PH domain-assisted nucleotide exchange and has been well characterized for a small subset 
of RhoGEFs, including Dbs [58] and Trio-N [59].  Collectively, the majority of data suggests 
that the PH domain serves to fine-tune the activity of the DH domain in the cell directly by 
mediating the engagement of regulatory proteins or indirectly by serving as hydrophobic 
tethers. 
The regulation of Dbl family GEFs can be as diverse as the 69 members, which 
comprise the family [55].  Dbl family members can be regulated by: gene transcription, such 
as Ect2 [69]; subcellular localization, such as Net1 [70]; homodimerization, such as β-Pix 
[71]; or tyrosine phosphorylation, such as Vav [72] and Tim [73].  An emerging theme 
among the Dbl family is their capacity to serve as signaling nodes by integrating upstream 
activators with downstream cascades [55].  For example, Tiam1 functionally couples the Ras 
signaling cascade to the activation of Rac1, by way of a Ras-binding domain (RBD) which 
directly engages activated Ras to enhance the Rac1-specific exchange activity of the DH-PH 
cassette.   
However, of particular significance to our study are Dbl family GEFs that are 
responsive to heterotrimeric G proteins, as this subset of molecules effectively integrates two 
major G protein signaling pathways.  Studies have shown that Dbl family members can be 
regulated by either activated Gα-subunits or liberated Gβγ-subunits via several mechanisms 
(Table 2).  Generally, Gβγ-subunits act as upstream activators of Rac1, while Gα-subunits act 
as upstream activators of RhoA.  The topic of Gα-subunits directly modulating the activity of 
Dbl family RhoGEFs will be further explored in depth below. 
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Assays for G protein function 
Our study of guanine nucleotide exchange of Rho has required the use of highly 
robust assays for small GTPase function.  However, historically, most methods for studying 
the activation of Ras superfamily GTPases have been sub-optimal and have relied upon 
radioactive forms of guanine nucleotides [74-76].  Typically in these assays, free nucleotides 
and inorganic phosphate are separated from nucleotide-bound forms of GTPases using 
differential binding to filters or activated charcoal.  Unfortunately, all such methods suffer 
from several intrinsic disadvantages arising from the need to separate bound and free 
nucleotides.  These disadvantages include extensive manual manipulations, limited data 
collection rates, low intrinsic precision, the production of radioactive wastes, and 
discontinuous monitoring of reaction kinetics.  Furthermore, the physical separation of 
reactants introduces potential anomalies resulting from perturbations in reactant 
concentrations and the possible destabilization of native proteins.   
Fortunately, advances in spectroscopic instrumentation and the production of a 
variety of fluorescent analogs of guanine nucleotides have enabled fluorescence-based 
assays, similar to those refined by Alfred Wittinghofer and colleagues [77], to become 
preeminent for studying many biochemical properties of G proteins.  These assays take 
advantages of spectroscopic differences between bound and unbound fluorescent analogs of 
guanine nucleotides to monitor the binding and hydrolysis of nucleotides as well as the 
interaction of GTPases with various effectors and regulators.  The most common analogs 
conjugate either Bodipy analogs [78] or Mant [79] fluorophores to the sugar hydroxyls of 
GDP, GTP, or non-hydrolysable forms of GTP, such as GTPγS.  These fluorescent 
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nucleotides are used to study GTPases of the Ras superfamily [80] as well as Gα-subunits 
[81-84].  
Fluorophores emit light at a higher wavelength (λem) when excited at certain 
wavelength (λex).  For example, excitation of the Mant fluorophore at 360 nm will result in a 
fluorescence emission at 440 nm.  Fluorophore-conjugated nucleotides have a low quantum 
yield of fluorescence in solution due to intermolecular quenching by solvent and 
intramolecular quenching by the guanine base.  However, upon binding to G protein, the 
fluorescence emission intensity from the fluorophore is greatly enhanced (Fig. 4).  The use of 
Mant-nucleotides for the study of Ras was first described by Neal et al. [80].  This study 
showed that binding Mant-GTP to Ras results in an increase in fluorescence intensity of 
about 3.2-fold.   
Our studies presented below take advantage of a fluorescence-based assay for G 
protein function, commonly referred to as a standard guanine nucleotide exchange assay (Fig. 
4).  The simplest fluorescence-based assay of nucleotide exchange is straightforward, rapid, 
and typically sufficient for monitoring GTPase activation in real-time.  This assay is useful 
for assessing the competence of GTPases to bind guanine nucleotides in the presence of 
limiting concentrations of Mg2+ as well as for the biochemical characterization of GEFs.  In 
this assay, a candidate GEF or EDTA, which can substitute as an artificial GEF, catalyzes the 
expulsion of nucleotide from the small GTPase.  Then, depending on which fluorescent 
nucleotide is predominant in solution, the fluorophore-conjugated nucleotide binds to the 
GTPase thereby causing an increase in the fluorescent signal.   
Fluorophores conjugated to both GDP and GTP can be used for this assay, as they 
will both bind to nucleotide-free G protein.  The GTPase is typically purified in a buffer 
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containing GDP, to facilitate interactions between the GEF and G protein and assure a low 
level of spontaneous nucleotide loading.  An alternate form of this assay uses Rho GTPases 
which have been preloaded with fluorescent nucleotide and is used when a kinetic rate of 
exchange (kobs) is to be measured.  In this assay, G protein is preloaded with fluorescent 
nucleotide, such as Bodipy-FL-GDP, and the exchange reaction is carried out in a solution 
containing an excess of non-fluorescent guanine nucleotide, such as GDP.  These and other 
applications of fluorescence-based assays for the study of Ras superfamily were the topic of a 
recent comprehensive review by our group [85].  Furthermore, these methods have been 
modified by our group for high-throughput drug screening purposes in order to identity novel 
small molecules which modulate the guanine nucleotide exchange cycle mediated by Rho 
GTPases and their Dbl family GEFs.   
Many of our studies presented in Chapter 2 utilize a selective activator of 
heterotrimeric Gα-subunits and warrants some further description of its mechanism of action.  
There is an extensive history behind the use of aluminum tetra-fluoride (AlF4) as both a 
selective activator of heterotrimeric Gα-subunits and as a tool to stabilize RGS-Gα-subunit 
interactions [86].  While Rall and Sutherland serendipitously discovered that fluorides 
activate AC, the effector of Gαs [87], it was Gilman and colleagues who later determined that 
this observation was attributed to AlF4 contamination directly activating the Gα-subunit from 
a heterotrimeric G protein [88].   
The mechanism of action was ultimately determined at atomic resolution; the AlF4 
ion resides in the γ-phosphate binding site of the Gα-subunit [11].  Subsequent studies 
showed that Gα-GDP-AlF4 and Gα-GTPγS take on the same activated conformation, but 
differ in the atomic coordination surrounding the γ-phosphate binding region.  The 
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coordination of GDP-AlF4 actually mimics the transition state of GTP hydrolysis as opposed 
to the GTP-bound “ground” state.  A strictly conserved arginine residue found in the helical 
domain and a glutamine residue in the Ras-like domain were found to be essential for 
stabilizing the AlF4 ion [86].  Indeed, these two residues are required for GTP hydrolysis, yet 
dispensable for GTP binding.  Moreover, mutation of the conserved glutamine to leucine 
(Q/L) produces a constitutively active Gα-subunit, which cannot hydrolyze GTP, and is a 
common method of activating Gα-subunits.  
In the case of Ras superfamily GTPases, such as Ras and Rho, only the glutamine 
residue is conserved and no arginine is present to stabilize the AlF4 ion.  Interestingly, the 
arginine residue found in hetereotrimeric Gα-subunits is the main catalytic residue utilized by 
GAPs for Rho GTPases, as well as other Ras superfamily members.  Small GTPases such as 
Ras and Rho will not bind AlF4 in the absence of a GAP, because the arginine residue 
required to stabilize the bound AlF4 ion is supplied in trans by the arginine finger of a GAP 
[86].  Yet heterotrimeric G-proteins will readily bind AlF4 because the arginine residue is 
supplied in cis by the all-helical domain.  Thus, exogenous addition of AlF4 will allow us to 
selectively activate heterotrimeric Gα-subunits during in vitro biochemical analysis without 
impacting biochemical properties of Rho GTPases present during experimental procedures 
presented below in Chapter 2. 
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Part 2: p63RhoGEF 
RhoA activation downstream of GPCRs 
It has long been appreciated that extracellular stimulation of GPCRs results in many 
diverse cellular responses dependent upon the activation of Rho GTPases including: (a) 
changes in cell morphology [89-94], (b) lipid metabolism [95-98], (c) vascular smooth 
muscle cell contraction and Ca2+ sensitization [99-111], (d) cell migration [112-114], (e) 
MAP kinase signaling and gene transcription [115-117], and (f) cell survival/apoptosis [115, 
118-124].  For example, while numerous groups had shown historically that serum is a potent 
inducer of actin cytoskeletal rearrangements, it was the pioneering studies of Ridley and Hall 
that first identified the lipid lysophosphatidic acid (LPA) as the essential component in serum 
responsible for these Rho-mediated events [90].  Their seminal work demonstrated that 
stimulation of GPCRs by LPA or bombesin resulted in the formation of stress fibers and 
focal adhesions in a Rho-dependent manner.  Numerous other groups have since well 
established the capability for GPCRs to induce Rho-mediated cellular responses.  For 
example, in Swiss-3T3 cells GPCR stimulation by LPA, endothelin, thrombin, and bombesin 
all result in Rho-dependent formation of stress fibers and focal adhesions [89, 91].  In 
neuronal cell lines, activation of GPCRs results in Rho-dependent cell rounding and neurite 
retraction [92-94, 125].  Additionally, studies have suggested that the oncogenic potential of 
many GPCRs including the mas oncogene, Par-1, and G2A receptors are dependent upon the 
activation of Rho GTPase signaling pathways [115, 119-122].  
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The Gα12/13-p115 family paradigm 
Johnson and colleagues were the first to demonstrate that the heterotrimeric G 
proteins Gα12 and Gα13 activated Rho-mediated signaling pathways [126].  Since then, 
numerous groups have shown that expression of activated Gα12/13 results in stress fiber 
formation, SRF-driven gene transcription, and an increase in GTP-bound RhoA.  However, 
the molecular pathway connecting activated Gα12/13 to Rho signal transduction was not 
determined until the discovery and characterization of p115-RhoGEF by Bollag and 
colleagues [127].  The p115 family of Rho-specific Dbl family GEFs includes p115-
RhoGEF, PDZ-RhoGEF, and leukemia-associated RhoGEF (LARG) [128, 129].  These 
family members are unique in their domain composition as they are the only Dbl family 
GEFs that contain a recognizable module for binding heterotrimeric G proteins; a highly 
divergent RGS domain.   
The exact mechanism by which p115 family GEFs are activated by heterotrimeric G 
proteins of the Gα12/13 family is not fully understood.  However, the accepted mode of 
action proposes that activated Gα12 or Gα13 binds to the RGS domain resulting in enhanced 
membrane localization [130] as well as conformational changes within the protein that work 
together to fully activate the guanine nucleotide exchange activity upon the Rho isoforms.  
Biochemical analysis of purified p115 family members has demonstrated that Gα13 can 
directly, albeit only modestly, stimulate p115-RhoGEF [127, 131-133] and LARG [132] to 
enhance in vitro guanine nucleotide exchange on RhoA.  Moreover, biochemical studies of 
isolated RGS domains from p115 family members indicate a high degree of specificity for 
Gα12/13 family members only [134, 135]. 
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Gαq/11 activates RhoA via a distinct, poorly understood mechanism 
While numerous studies demonstrate that Gα12/13 leads to RhoA activation via direct 
engagement of p115 family members, a growing body of literature also implicates Gαq/11 
family members as activators of RhoA which function via a unique, albeit poorly understood, 
mechanism.  For example, expression of activated Gαq leads to neurite retraction and cell 
rounding in NGF-differentiated PC-12 cells in a Rho-dependent manner [136].  Moreover, 
expression of activated forms of the Gαq/11 family members or heterologous expression of 
Gαq/11-coupled receptors leads to an increase in levels of RhoA-GTP as measured by 
preferential affinity precipitation in HEK-293 cells [107, 137, 138].  Expression of the other 
Gαq/11 family members Gα11, Gα14, and Gα15/16 additionally leads to an increase in SRF-
driven gene transcription [116, 138] and elevated RhoA-GTP levels [137].  Expression of 
activated Gαq also induces stress fiber formation in: (a) confluent quiescent Swiss-3T3 cells 
in a RhoA- and ROCK-dependent manner [137], (b) in HEK-293 cells [107], and (c) in 
mouse embryonic fibroblasts (MEFs) [139].   
Extracellular stimulation of numerous Gαq/11-coupled GPCRs or their heterologous 
expression also results in downstream activation of Rho-mediated gene transcription using an 
SRF-driven promoter gene reporter assay [116, 138, 140-142].  MEFs which heterologously 
express the rat metabotropic glutamate receptor (mGluR1α) or the human M1-cholinergic 
receptor (M1R) have significantly reduced ability to induce stress fiber formation in Gαq/11-
deficient cells [141], suggesting that Gαq/11 mediates RhoA activation downstream of these 
GPCRs.  Furthermore, HEK-293 cells that express the angiotensin II receptor (AngIIAT1AR), 
in a stable manner, activated RhoA and induced stress fiber formation in a Gαq/11-dependent 
manner [107].  This study by Barnes and colleagues further demonstrated that Gαq/11-
 21
mediated activation of RhoA is independent of classical PLC-β signaling, as treatment with 
pharmacological inhibitors of PLC-β isozymes or Ca2+ mobilization did not impact RhoA 
activation in response to angiotensin II stimulation [107].   
Overexpression of activated heterotrimeric G proteins or heterologous expression of 
Gαq-coupled receptors does not always reflect endogenous GPCR-Gα signaling.  Moreover, 
the complexity inherent in the coupling of GPCRs to several different Gα-subunit families 
makes the study of endogenous GPCR stimulation extraordinarily difficult.  Vogt and 
colleagues circumvented this issue by utilizing MEFs deficient in various Gα-subunits to 
determine which Gα-mediated signaling pathways were responsible for RhoA activation by 
the ligands thrombin, LPA, and bradykinin [139].  Gα-subunit selectivity for the GPCRs 
which bind these ligands can be promiscuous for Gα-subunits of the Gαq/11, Gα12/13, and 
Gαi/o families.  Therefore, this group utilized MEFs deficient in Gα12/13 or Gαq/11 in 
coordination with pertussis toxin treatment, which inhibits Gαi/o family members.  This 
study demonstrated that GPCR stimulation by thrombin, LPA, and bradykinin results in 
RhoA activation primarily by coupling to Gαq/11 [139].  Moreover, this study determined 
that Gαq/11-mediated activation of RhoA occurred independent of PLC-β/Ca2+ signaling as 
inhibition of these pathways did not significantly impact RhoA activation [139].  Only a 
handful of conflicting reports suggest that additional unknown factors or differences in cell 
types may impact the ability for Gαq/11 to activate RhoA [126, 143, 144].  Yet, taken 
together, there is overwhelming evidence RhoA is activated downstream of Gαq/11-mediated 
signaling.   
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p63RhoGEF is a potential link between Gαq/11 and RhoA 
Many groups have attempted to link p115 family members as important regulators of 
Gαq-RhoA signaling with mixed and often conflicting results.  The RGS domain of LARG 
reportedly interacts with AlF4-activated Gαq in NIH-3T3 cells and was shown to attenuate 
Gαq-driven SRF activation when overexpressed in NIH-3T3 cells [145].  The RGS domain 
of LARG also reduced the amount of RhoA-GTP levels and stress fiber formation in 
pertussis toxin treated Gα12/13-deficient MEFs stimulated with LPA, thrombin, and 
bradykinin, suggesting that the LARG RGS domain extends specificity beyond Gα12/13 to 
additionally inhibit Gαq/11 [139].  Yet LARG, p115-RhoGEF, and PDZ-RhoGEF are well 
characterized for their ability to specifically regulate Gα12/13 and not Gαq/11 [134, 135].  
Moreover, the LARG RGS domain did not bind activated Gαq using co-immunoprecipitation 
in HEK-293 cells [128].  Furthermore, expression of the RGS domains from LARG and 
PDZ-RhoGEF did not significantly inhibit Gαq-driven SRF activation in NIH-3T3 cells 
[128].   
Chikumi et al. reported a negligible amount of activated Gαq binding to LARG, 
p115-RhoGEF, and PDZ-RhoGEF that was described as “limited but reproducible” using co-
immunoprecipitation experiments in HEK-293 cells; peculiarly this “interaction” was not 
mediated by the RGS domain [138].  This group later speculated that activated Gαq was 
interacting with p115 family members via a “unique mechanism” that was RGS domain-
independent.  Unfortunately, collectively these unconvincing data do little to clarify the 
mechanism by which Gαq activates RhoA and are inconclusive in their attempt to implicate 
LARG and other p115 family members.    
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While previous work has attempted to “shoehorn” Gαq into the p115 family paradigm 
for RhoA activation, more recent evidence suggests that p63RhoGEF functionally couples 
Gαq to RhoA activation via a distinct mechanism.  p63RhoGEF, and its splice variant GEFT, 
which lacks the first ~100 amino acids, are ubiquitously expressed and often co-expressed in 
many tissue and cell types but are enriched in the brain and heart [146-148].  Notably, studies 
indicate that p63RhoGEF and GEFT are functionally redundant.  Several lines of evidence 
have implicated p63RhoGEF/GEFT in: (a) muscle regeneration and myogenesis in skeletal 
muscle [149], (b) regulation of cardiac sarcomeric actin [147], (c) cell proliferation and 
migration [148], and (d) dendritic spine formation and neurite outgrowth [150, 151].   
However, Lutz and colleagues were the first to report p63RhoGEF as a potential link 
between Gαq/11 and RhoA (Fig. 5) [152].  Interestingly, p63RhoGEF does not contain any 
recognizable domains outside of the canonical DH-PH cassette nor does it bear any 
significant homology to p115 family members.  This study, by Lutz and colleagues, showed 
that p63RhoGEF synergistically activates SRF-driven gene expression in coordination with 
activated Gαq and Gα11.  Additionally, heterologous expression of the Gαq/11-coupled 
histamine H1 receptor (H1R) and the M3-cholinergic receptor (M3R) synergized with 
p63RhoGEF to activate SRF-driven gene expression in HEK-293 cells.  Significantly, this 
synergy was not recapitulated by activated Gα12 or Gα13.  Heterologous expression in HEK-
293 cells of the Gαq-specific RGS domain of RGS2 inhibited this activation, while 
expression of the Gα12/13-specific RGS domain of p115-RhoGEF had no effect [152].   
However, many of the results presented by Lutz et al. were dependent upon the use of 
SRF-driven gene reporter assays, which do not always reflect specific activation of the RhoA 
isoforms [117].  Using a more physiologically relevant Rho pull-down assay, this group 
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further illustrated that expression of activated Gαq and Gα11, but not Gα12 or Gα13 
synergizes with p63RhoGEF to increase levels of RhoA-GTP in HEK-293 cells [152].  Using 
truncation mutants of p63RhoGEF, this group concluded that a region encompassing the PH 
domain to C-terminus (PH-Ct) was important for interacting with Gαq/11.  Full-length 
p63RhoGEF and p63RhoGEF (PH-Ct) were used to co-immunoprecipitate activated Gαq and 
Gα11, but not Gα12 or Gα13 in HEK-293 cells.   
Interestingly, the PH-Ct fragment displayed a classical dominant-negative phenotype, 
presumably by sequestering activated Gαq/11.  That is, expression of PH-Ct inhibited SRF 
activation mediated by full-length p63RhoGEF or stimulation of the M3R.  Moreover, this 
group demonstrated functional competition of p63RhoGEF and PLC-β for activated Gαq.  
Taken together, these data strongly suggest a model by which activated Gαq/11 activates 
p63RhoGEF, either directly or indirectly, to stimulate guanine nucleotide exchange on RhoA, 
a model distinct from that of the conventional p115 family. 
 
Part 3: SmgGDS 
Atypical GEFs for Rho subfamily GTPases 
As described above, there are approximately 69 Dbl family GEFs, which are multi-
domain containing proteins implicated in numerous signaling cascades (Fig. 3) [55].  
However, recent evidence suggests that proteins outside of the Dbl family also function as 
non-conventional or atypical GEFs for Rho GTPases.  Candidate atypical GEFs for Rho 
GTPases currently described in the literature include the bacterial toxin SopE, the CZH 
family proteins, including Zizimin1 and Dock180, the phospholipid-binding protein SWAP-
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70, and the armadillo repeat-containing protein SmgGDS.  These atypical GEFs share no 
sequence or structural homology with the conserved regions of the catalytic DH domain of 
Dbl family proteins (Fig. 6) and likely utilize novel means to engage Rho GTPases.  
Additionally, these various atypical RhoGEFs lack any overall sequence or structural 
similarity with each other.   
While the general mechanism of guanine nucleotide exchange and basis for substrate 
binding specificity of the Dbl family GEFs has been extensively studied at atomic resolution, 
the mechanism by which non-conventional GEFs engage and activate Rho subfamily 
members has not been well characterized.  Like Dbl family GEFs, these atypical GEFs are 
thought to lower the activation energy required to achieve the nucleotide-free state of the Rho 
GTPase, thereby facilitating the release of bound nucleotide and promoting its exchange.   
Although a similar general mechanism of action is believed to underlie catalysis by 
both non-conventional GEFs and Dbl family GEFs, the structural requirements and catalytic 
residues involved are unique.  This is illustrated by the only known structure of a non-
conventional RhoGEF, the bacterial toxin SopE bound to nucleotide-free Cdc42 [153].  
Many bacterial pathogens have evolved several mechanisms, which highjack Rho GTPase 
signaling pathways within a host cell in order to modulate the actin cytoskeleton and make 
host cells more susceptible to invasion [154].  In this manner, Salmonella typhimurium 
injects SopE into a host cell and transiently modulates Rac1 and Cdc42 activity by acting 
directly as a RhoGEF towards these GTPases.   
The structural elucidation of SopE bound to Cdc42 has illustrated that a conserved 
mechanism of nucleotide exchange is shared by both bacterial SopE and eukaryotic Dbl 
family GEFs.  Both SopE and Dbl family GEFs, such as Dbs, stabilize a near identical 
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conformation of the bound GTPase that is incompatible with guanine nucleotide binding 
(Fig. 7).  Although Dbl family GEFs and the bacterial GEF SopE both promote nucleotide 
exchange via a similar mechanism, the catalytic residues required for exchange are not 
conserved, nor is the tertiary fold of these RhoGEFs, suggesting that other non-conventional 
RhoGEFs may also stabilize a nucleotide-free state of the GTPase while utilizing unique 
catalytic residues and novel folds.   
The Ced-5/Dock180/Myoblast city-Zizimin homology (CZH) family of non-
conventional RhoGEFs is composed of 11 human members each containing a C2 lipid-
binding domain, an array of armadillo repeats, and two conserved regions termed CZH1 and 
CZH2 which are thought to be important for GTPase binding and guanine nucleotide 
exchange (Fig. 6) [155].  The prototypical CZH family members are Dock180 and Zizimin1; 
Dock180-like proteins catalyze nucleotide exchange on Rac1, while Zizimin1-like proteins 
are specific for Cdc42.  Dock180 functions as an obligate heterodimer by binding to ELMO 
via several interactions, including a SH3-polyproline interaction.  Dock180 requires ELMO 
to promote guanine nucleotide exchange specifically on Rac1, leading to regulation of cell 
migration and engulfment.  This mechanism of a bipartite GEF in which Dock180 requires 
ELMO for activity is conserved in other Dock180-like proteins, suggesting a general 
mechanism for exchange within this family.  However, Zizimin1-like CZH proteins are 
thought to function as homodimers via a C-terminal coiled-coil region and do not bind to 
ELMO-like accessory proteins.  Very little is known regarding the biochemistry of guanine 
nucleotide exchange mediated by the CZH family; this is largely due to the lack of highly 
purified protein samples for in vitro characterization.  
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SWAP-70 was previously characterized as a component of B-cell activation and 
immunoglobulin class switching [156], but was later shown to be a Rac1-specific exchange 
factor that lies downstream of PI3-K [157].  Upon growth factor stimulation and PI3-K 
activation, SWAP-70 translocates to the plasma membrane upon binding PI(3,4,5)P3 
specifically via a PH domain.  Although poorly characterized, both SWAP-70 and the related 
protein IBP [158] are thought to be non-conventional GEFs for Rac1.  
An emerging theme among atypical Rho exchange factors is the presence of 
armadillo (ARM) repeats.  CZH family proteins contain a large region of ARM repeats 
among other signaling domains, while SmgGDS consists exclusively of ARM repeats (Fig. 
6).  Proteins that contain ARM repeats comprise a large, diverse, and evolutionarily 
conserved group involved in nuclear transport, maintenance of cell-cell junctions, and 
regulation of actin/myosin cytoskeletal structures [159].  ARM repeats are modular motifs of 
~40 amino acids which are structurally characterized by three α-helices (Fig. 8) [160].  The 
structures of numerous ARM repeat proteins, including Importin-α [161], β-catenin [162], 
and Plakophilin1 [163], has revealed that multiple ARM repeats stack to form large super-
structures that resemble a superhelix or solenoid-like structure.  These superstructures display 
varying amounts of curvature and can have large insertions in between ARM repeats [163].  
The protein-protein interaction region is typically composed of an inner groove, which is 
formed by the third helix of each individual ARM repeat.  The founding member of this 
protein family is the Drosophila melanogaster gene armadillo, mutation of which resulted in 
segmentation defects reminiscent of the ridges on the back of an armadillo [164].  ARM 
repeats are highly related to HEAT repeats, with subtle structural differences [165].  In 
addition to the CZH family proteins and SmgGDS, recently the ARM repeat containing 
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protein p120-catenin was also shown to regulate Rho GTPase signaling [166-168]; however, 
in this case, p120-catenin is a negative regulator of RhoA and not an exchange factor.  
 
Early characterization of SmgGDS as a non-specific GEF 
Numerous papers have been published on SmgGDS, although often times the data is 
in direct contrast to previous reports, even within the same research group.  Nevertheless, 
some common observations among various studies warrant a detailed review of this 
literature.  SmgGDS was first identified in 1990 as a GDP dissociation stimulator (GDS) 
purified from cow brain lysates by a research group headed by Yoshimi Takai [169].  In fact, 
a majority of the early characterization of SmgGDS was performed solely by the Takai 
group.  Using only partially purified protein, this group suggested that this new exchange 
factor was specific for RhoA and RhoB, but not H-Ras, Rap1A, nor Rab1A.  Subsequent 
studies further purified SmgGDS isolated from cow brain lysates and demonstrated that 
SmgGDS exchanges guanine nucleotide on Rap1A and Rap1B, but not H-Ras, RhoB, nor 
Rab1A [170, 171].  This group named the exchange factor they isolated smg p21 GDS, based 
upon its ability to activate Rap, which was historically referred to as smg p21. 
The cDNA for bovine [172] and human [173] SmgGDS were then cloned and 
expressed in recombinant form for use in characterizing the biochemistry of SmgGDS-
mediated guanine nucleotide exchange.  Smg p21 GDS was renamed SmgGDS during a 
study that demonstrated that only lipid-modified versions of the substrate GTPases RhoA, K-
Ras, and Rap1B were activated by SmgGDS [174].  Several reports thereafter focused on the 
necessity for lipid-modified substrates in order for SmgGDS to catalyze guanine nucleotide 
exchange [175-182].  The source for these lipidated GTPases varied from purified tissue 
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samples to isolation from Sf9 insect cells.  As long as the GTPase was lipid-modified, the 
source reportedly did not impact substrate recognition by SmgGDS [174].  Although the 
substrate GTPase specificities of SmgGDS in these studies were not in complete agreement, 
generally they suggested that SmgGDS is an exchange factor for prenylated forms of Rap, K-
Ras, Rac1, and RhoA.  This necessity for lipid-modification of the substrate GTPase 
prompted several studies which suggested that SmgGDS extracts membrane-bound GTPase, 
similar to RhoGDI [171, 183].  Additionally, early studies investigating the cellular roles of 
SmgGDS in relation to Rap signaling [184, 185], NADPH oxidase [186], and cellular 
transformation [187, 188] did little to clarify the cellular function of SmgGDS.   
All of these early biochemical reports, however, relied on sub-optimal methodologies 
for assessing guanine nucleotide exchange and rarely contained sufficient controls to 
unequivocally implicate SmgGDS as a bona fide GEF.  For instance, GEFs all preferentially 
interact with the nucleotide-free form of the substrate GTPase.  Yet, these early studies did 
not adequately address this; moreover, some studies showed that either GDP-bound or GTP-
bound GTPases bind SmgGDS [171, 181].  We believe that the early characterization of 
SmgGDS as a non-specific GEF may have been inaccurate based on lack of appropriate 
controls, a dearth of highly purified protein components, and a reliance on sub-optimal 
methodologies for quantifying guanine nucleotide exchange.  The saving grace of many of 
these studies is the fascinating observation that the preferred GTPase substrate of SmgGDS is 
apparently RhoA, as SmgGDS was more active upon RhoA than any other Ras superfamily 
GTPase tested [174, 179, 189].     
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Recent biochemical and cellular characterization of SmgGDS 
Subsequent to these early studies, which were dominated by the Takai group, several 
independent lines of evidence indicated that lipid-modification was not essential for the 
GTPase substrates of SmgGDS [190-193].  In one of these studies comparing multiple Ras 
superfamily GTPase substrates for SmgGDS, the preferred substrate again appeared to be 
RhoA [190].  Moreover, one of the most rigorous biochemical characterizations of SmgGDS, 
the only one of its kind to utilize real-time fluorescence-based guanine nucleotide exchange 
assays, clearly demonstrated guanine nucleotide exchange of non-lipidated RhoA and was 
the exclusive substrate used for this study [192].  Notably, in this study, as well as others, 
high concentrations of SmgGDS, typically in large excess of the target substrate GTPase, 
were required to observed guanine nucleotide exchange [192].   
Several reports probing the cellular roles of SmgGDS have demonstrated in vivo 
activation of Rap1 [194] or Rap and RalA [195] in HEK-293 cells.  However, SmgGDS only 
weakly induced Elk-1-driven gene reporters, which are diagnostic for Ras/Rap activation 
[195].  One study identified SmgGDS by using a co-immunoprecipitation assay to discover 
proteins that preferentially bind nucleotide-free forms of H-Ras and K-Ras [193].  
Interestingly, this group did not pull-down classically described Ras-GEFs such as Sos1 or 
Ras-GRF.  Yet, SmgGDS was unable to catalyze guanine nucleotide exchange on H-Ras or 
N-Ras in vitro.  However, the authors did demonstrate in vitro guanine nucleotide exchange 
upon non-lipidated RhoA [193] further suggesting that RhoA is the preferred substrate of 
SmgGDS.   
There are only two non-GTPase binding partners reported for SmgGDS: (1) 
SMAP/KAP3 and (2) β-Pix.  SMAP (SmgGDS-associated protein), was identified using 
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yeast two-hybrid approach to discover interacting partners for SmgGDS [196].  While 
SmgGDS and SMAP were shown to bind directly, the authors could not implicate a 
physiological role for this interaction.  Moreover the authors convey that SMAP does not 
modulate the in vitro exchange activity of SmgGDS [196].  SMAP is also known as KAP3 
and binds to microtubule-associated kinesin motors [197, 198], which are implicated in the 
anterograde transport of organelles [199].   
The most recent cellular characterization of SmgGDS suggests it is an accessory 
protein for the Dbl family GEF β-Pix [200].  The authors were exploring potential 
mechanisms for their observed sustained Rac1 activation downstream of β-Pix as most Dbl 
family GEFs display transient activation of GTPases in cells.  Interestingly, this Rac1 
activation was not dependent upon the DH-PH cassette of β-Pix, but was mapped to a 
separate domain, the GIT-binding (GB) domain.  The authors showed convincingly that 
SmgGDS interacts with β-Pix and Rac1 via the GB domain and that SmgGDS was required 
for Rac1 activation by the GB domain of β-Pix [200].  Moreover, siRNA-mediated depletion 
of SmgGDS reduced the capacity for the β-Pix to mediate neurite outgrowth in bFGF-
stimulated PC-12 cells.  Based on their findings, the authors speculated that β-Pix and 
SmgGDS form a complex to facilitate sustained Rac1 activation downstream of growth 
factor stimulation, resulting in neurite extension [200].     
However, the most intriguing and perhaps the most persuasive cellular studies have 
recently come out of the Carol Williams group, which suggest that SmgGDS plays a cellular 
role in the cytoplasmic-nuclear shuttling of Rho GTPases.  This group first crossed paths 
with SmgGDS during a study of dominant negative and constitutively active mutations 
within RhoA [201].  The authors used HA-tagged RhoA constructs to pull-down endogenous 
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binding partners in CHO cells.  The authors discovered a 60 kDa protein that selectively 
interacted with dominant-negative RhoA, but not wild-type or constitutively active RhoA.  
Enzymatic digestion coupled with peptide sequencing subsequently identified this protein as 
SmgGDS.  Interestingly, the authors were unable to pull-down any Dbl family members 
using this approach, even though they were able to show that several RhoA-specific Dbl 
family GEFs were expressed in their cell line [201].   
Next, the authors used immunofluorescence microscopy to characterize the sub-
cellular distribution of several RhoA constructs [201].  Wild-type and constitutively active 
RhoA were evenly distributed within the nucleus, cytoplasm, and cell-cell junctions.  
However, dominant negative RhoA was excluded from the nucleus and cell-cell junctions 
and localized to the cytoplasm and perinuclear region [201].  Of particular significance was 
the finding that co-expression of SmgGDS with wild-type RhoA recapitulated the dominant-
negative distribution phenotype, excluding RhoA from the nucleus, while expression of 
RhoA-specific Dbl family GEFs did not alter distribution of wild-type RhoA.  The group 
later showed that this phenomenon was mediated by a functional nuclear export signal (NES) 
within SmgGDS [202].  Expression of wild-type SmgGDS results in primarily cytosolic 
distribution, however mutation of a functional NES within SmgGDS induces nuclear 
accumulation [202].  Moreover, coexpression of dominant-negative RhoA with wild-type 
SmgGDS further restricts SmgGDS localization to the cytosol.     
The Williams group noted that the C-terminal polybasic region (PBR) of certain Rho 
GTPases contain a canonical nuclear localization signal (NLS) [203].  Rac1 and RhoC have 
an NLS that is evolutionarily conserved, while Rac2, Rac3, RhoA, and RhoB lack an NLS.  
Furthermore, activated Rac1 accumulates in the nucleus dependent upon the NLS within the 
 33
PBR [202].  This intriguing result is corroborated by previous studies demonstrating real-
time Rac1 activation within the nucleus of living cells [204].  The presence of an NLS on a 
small GTPase of ~21 kDa is counterintuitive, as molecules smaller than ~40 kDa are reported 
to readily diffuse into the nucleus through large nuclear pore complex openings [205].  That 
is unless, the Rho GTPase utilizes an NLS to translocate larger protein complexes into the 
nucleus.  This was demonstrated when coexpression of SmgGDS with activated Rac1 was 
sufficient to drive SmgGDS into the nucleus, dependent upon the NLS of Rac1 [202].   
The physiological significance of Rac1 in the nucleus is not well understood, 
however, the Williams group has provided evidence that nuclear-localized Rac1 is targeted to 
proteosomal degradation via the C-terminal PBR [206].  Despite these intriguing findings, 
there is no cohesive model that can adequately describe the mechanisms underlying nuclear-
cytoplasmic distributions of SmgGDS.  Moreover, it remains unknown how SmgGDS-Rac1 
nuclear targeting relates to the more conventional nuclear shuttling mechanisms typified by 
the Importins and Karyopherins [205].   
Several lines of evidence suggest that physiologically, SmgGDS is a regulator of 
cellular growth [207].  For instance, SmgGDS-null mice exhibit post-natal lethality 
stemming from enhanced cell death in cardiomyocytes, thymocytes, and neuronal cells [208].  
Ex vivo cultured SmgGDS knock-out thymocytes were ~3-4 times more sensitive to 
apoptosis stimuli, which could be rescued by reintroduction of SmgGDS [208].  Reduction of 
endogenous SmgGDS in non-small cell lung carcinoma cell lines using siRNA was sufficient 
to inhibit DNA synthesis, cell proliferation, and cell migration [209].  Additionally, reduction 
of endogenous SmgGDS in an immortalized vascular smooth muscle cell line using siRNA 
resulted in a reduction of DNA synthesis and induced changes in cell morphology through 
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the disruption of myosin filament organization [210].  SmgGDS has also been identified as 
an up-regulated gene in human lung squamous cell carcinoma, where expression in lung 
tumor samples was elevated greater than 50% when matched to normal tissue [211].  The 
SmgGDS gene also maps to a chromosomal region which is frequently deleted in primary 
hepatocellular carcinoma [212].   
SmgGDS is also a target of chromosomal rearrangements in leukemias.  Interestingly, 
the partner fusion protein is a component of the nuclear pore complex, lending credence to a 
nucleo-cyplasmic role for SmgGDS.  NUP98 (nucleoporin of 98 kDa) is a component of the 
nuclear pore complex that mediates nucleo-cytoplasmic shuttling of proteins.  An N-terminal 
region rich in phenylalanine-glycine (FG) repeats interacts with nuclear shuttling proteins at 
the nuclear pore complex, facilitating bi-directional passage to and from the nucleus [205].  
In all cases of leukemia-associated chromosomal rearrangements involving NUP98, the N-
terminal FG repeats are intact and fused to the N-terminus of the rearrangement partner.  
NUP98 is found fused to over a dozen distinct partner proteins.  Among these was the gene 
for SmgGDS (RAP1GDS1), which was reported to be a rearrangement partner with NUP98 
in a subset of patients with T-cell acute lymphocytic leukemias (T-ALL) [213-215].  In each 
of these cases, full-length SmgGDS was fused in-frame C-terminal to the NUP98 FG repeat 
region.   
Interestingly, every reported fusion partner for NUP98 is an essential regulator of 
gene transcription, with the exception of SmgGDS and the cytoskeletal assembly protein 
Adducin 3 [216].  The most common partner genes for NUP98 fusion, with over 30 reported 
patient cases, are the homeodomain-containing proteins, which are DNA-binding proteins 
that regulate gene transcription [217].  Other fusion partners implicated in gene transcription 
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include SET domain containing genes, which regulate gene transcription by methylating 
lysine residues on histones, transcriptional coactivators, DNA topoisomerases and, RNA 
helicases [217].   
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Dbl-family 
member 
PH domain-mediated 
binding partner Reference: 
Dbs Rac1-GTP [66] 
Scambio Rac1-GTP [68] 
Tiam1 Rap1A-GTP [67] 
Vav2 Rap1A-GTP [67] 
GEF-H1 Cingulin [218] 
Kalirin-N TrkA [219] 
Trio-N Filamin [220] 
Dbl Ezrin [221] 
 
Table 1: Dbl-family GEFs regulated via protein-protein interactions with the DH-associated PH 
domain.  
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Dbl-family 
member 
Binding 
partner 
Domain mediating 
interaction 
Substrate Rho 
GTPase Reference
P-Rex Gβγ DH Rac1  (direct activation) [222] 
Ras-GRF Gβγ unknown Rac1 [223] 
p114-RhoGEF Gβγ DH-PH RhoA [224] 
Dbl Gβγ N-terminal motif RhoA, Rac1, Cdc42 [225] 
Dbs Gβγ N-terminal motif Rac1, Cdc42 [225] 
Kalirin Gβγ N-terminal motif Rac1, RhoG [225] 
p115-RhoGEF Gα13 RGS RhoA  (direct activation) [127, 133] 
p115-RhoGEF Gα12/13 DH-PH RhoA  (direct binding) [133] 
PDZ-RhoGEF Gα12/13 RGS RhoA [226] 
LARG Gα12/13 RGS RhoA [145] 
LARG Gαq/11 RGS RhoA [145] 
p63RhoGEF Gαq/11 PH-C-terminus RhoA [146] 
 
Table 2: Dbl-family GEFs regulated by heterotrimeric G proteins.  
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Ras-superfamily 
GTPase SmgGDS is an GEF SmgGDS is not a GEF 
Rap1A [170, 179, 190] n/a 
Rap1B [170-172, 174, 175, 177, 184, 185] n/a 
RhoA [169, 173, 174, 176, 179, 189, 190, 192, 193] n/a 
RhoB [169, 174] [170] 
Rac1 [178-180, 189, 190] n/a 
Rac2 [178, 190, 191] n/a 
Rab1A n/a [174] 
Rab1B n/a [169, 170] 
H-Ras n/a [169, 170, 174, 193] 
K-Ras [174, 179] n/a 
Cdc42 (isoform1) [190] n/a 
 
Table 3: Previously published SmgGDS target GTPase substrates. 
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Figure 1: Signaling pathways regulated by heterotrimeric Gα-subunits. 
A multiple sequence alignment of the human Gα-subunits was used to construct a phylogenetic tree. 
The major subfamilies are grouped as follows: purple, Gαi/o; red, Gαq/11; green, Gαs; blue, 
Gα12/13. Major signaling pathways regulated by these subfamily members are additionally shown. 
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Figure 2: Signaling pathways regulated by Rho subfamily GTPases.   
A multiple sequence alignment of the human Rho GTPases was used to construct a phylogenetic tree. 
The well characterized family members Rho, Rac, and Cdc42 are highlighted in red, blue, and green, 
respectively. Constitutive activation of Rho, Rac, and Cdc42 results in actin-based cytoskeletal 
rearrangements leading to stress fibers and focal adhesions, lamellipodia, and filopodia, respectively. 
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Figure 3: Dbl family GEFs. 
A multiple sequence alignment of the DH domain from human Dbl family was used to construct a phylogenetic tree. The domain architecture for 
each family member is indicated, as are the Rho substrate specificities. The Trio/Kalirin/p63RhoGEF-subgroup is highlighted. Figure was adapted 
from Rossman et al., 2005. 
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Figure 4: Guanine nucleotide exchange.   
(A) The guanine nucleotide exchange cycle is regulated by: guanine nucleotide exchange factors 
(GEFs), which catalyze the release of bound nucleotide; GTPase accelerating proteins (GAPs), which 
enhance the intrinsic rate of GTP hydrolysis; and guanine nucleotide dissociation inhibitors (GDIs), 
which prevent the G protein from engaging in the cycle. (B) Fluorescent nucleotides can be used as 
probes for Rho GTPase activation by Dbl family RhoGEFs; left panel, unbound fluorophore-
conjugated guanine nucleotides (GTP*) are quenched in solution and emit a weak fluorescence signal 
(λem) upon excitation (λex). Right panel, however, when a GEF catalyzes guanine nucleotide 
exchange, the fluorophore-conjugated guanine nucleotides (GTP*) bind to the Rho GTPase, and have 
an increased fluorescence emission upon excitation. 
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Figure 5: Summary of results from Lutz et al., 2005.   
Lutz and coauthors demonstrated that overexpressed p63RhoGEF synergizes activated Gαq/11- but 
not Gα12/13-induced SRF and RhoA activation. Overexpressed p63RhoGEF also synergized with 
GPCR-mediated SRF activation via the M3 muscarinic receptor and the H1 histamine receptor; 
overexpression of the RGS domain of RGS2 inhibited this effect. Overexpression of p63RhoGEF 
inhibited the activity of PLC-β and vice versa. Co-immunoprecipitation studies also demonstrated 
that a fragment of p63RhoGEF encompassing the PH-C-terminus associated with activated Gαq/11. 
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Figure 6: Atypical guanine nucleotide exchange factors for Rho subfamily GTPases.   
The domain architecture and published target GTPase substrate specificity are shown for atypical RhoGEFs, which lack the canonical DH-PH 
cassette defined by the Dbl family. Zizimin1 and Dock180 are members of the CZH family, defined by the presence of CZH1 and CZH2 domains 
essential for guanine nucleotide exchange. Dock180 requires the accessory protein ELMO to function, while Zizimin1 most likely functions as a 
homodimer. SopE is a bacterial toxin which highjacks the cytoskeletal machinery of host cells during invasion, while SWAP-70 is not well-
characterized. SmgGDS has been reported to activate numerous Ras and Rho GTPases. 
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Figure 7: Structural comparison of the atypical Cdc42 exchange factor SopE to the Dbl family 
member Dbs. 
The crystal structures of SopE bound to nucleotide-free Cdc42 (left panel) and the crystal structure of 
Dbs DH-PH domains bound to nucleotide-free Cdc42 (right panel) are shown to demonstrate the 
structural differences between an atypical RhoGEF and a Dbl family GEF. 
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Figure 8: Armadillo repeats. 
Armadillo (ARM) repeats are sequentially repeated motifs that form a superhelix in the context of 
full-length protein, such as Importin-α depicted on left. The individual ARM repeat motifs are ~40 
amino acids and are structurally composed of two small α-helices followed by a third large α-helix. 
Two ARM repeats are illustrated at right to highlight their modular nature.  
 CHAPTER 2: G-ALPHA-Q DIRECTLY ACTIVATES P63RHOGEF VIA A 
CONSERVED EXTENSION OF THE DH-ASSOCIATED PH DOMAIN 
Background 
Rho GTPases are integral regulators of gene transcription and actin cytoskeletal 
remodeling during many dynamic cellular processes [34, 48].  Signal transduction cascades 
mediated by Rho GTPases originate via the extracellular stimulation of transmembrane 
receptors such as GPCRs, receptor tyrosine kinases, cytokine receptors, and integrins.  Of the 
22 human Rho subfamily members, RhoA, Rac1, and Cdc42 are the most characterized, 
stemming from their ability to induce striking changes in cellular morphology upon 
activation [35].   
Numerous studies have established that RhoA activation downstream of GPCRs is 
vital for a multitude of diverse physiological responses including cell migration [112], lipid 
metabolism [98], vascular smooth muscle cell contraction [102, 103, 105], and cell 
survival/apoptosis [115, 120, 123, 124].  GPCR-mediated activation of RhoA effectively 
couples signaling pathways mediated by two distinct groups of guanine nucleotide binding 
proteins: the heterotrimeric Gα-subunits and the monomeric small GTPases.  These two 
groups of G proteins share a universal mechanism for guanine nucleotide binding, GTP 
hydrolysis, and conformational switching between two discrete states: a GDP-bound inactive 
state and a GTP-bound active state [2].  Guanine nucleotide exchange factors (GEFs) activate 
G proteins by promoting the release of bound GDP, allowing the subsequent binding of GTP.  
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Active, GTP-bound G proteins can then interact with numerous downstream effector 
molecules, further propagating the signal initiated at the plasma membrane. 
GPCRs function as GEFs for heterotrimeric Gα-subunits, while Dbl family GEFs are 
the major class of exchange factors for Rho GTPases.  Dbl family GEFs are defined by the 
presence of a Dbl homology domain (DH domain) which is almost invariantly followed by a 
pleckstrin homology domain (PH domain) [55].  The catalytic guanine nucleotide exchange 
activity resides entirely within the DH domain, although recent evidence indicates that the 
PH domain can function to fine-tune this exchange activity [58, 59].  Previous studies have 
focused on the DH-associated PH domain as a simple membrane targeting device, by virtue 
of its ability to bind phosphoinositides.  However, emerging evidence suggests that PH 
domains may also play important regulatory roles by serving as protein-protein interaction 
modules [61].   
The coordinated crosstalk from GPCR stimulation to RhoA activation is mediated by 
Dbl family GEFs which are responsive to activated Gα-subunits.  A growing body of 
literature implicates both Gα12/13 and Gαq/11 family members as upstream activators of 
RhoA [128, 227, 228].  Moreover, members of the Gα12/13 and Gαq/11 families utilize 
distinct pathways to signal downstream to RhoA [136].  RhoA activation downstream of the 
Gα12/13 family is mediated by the p115 family members, which consists of p115-RhoGEF, 
PDZ-RhoGEF, and LARG.  The p115 family members are directly activated by Gα12/13 via 
a protein-protein interaction mediated by a highly divergent regulator of G protein signaling 
(RGS) domain, but are not activated by Gαq/11 family members [127, 131-133].  Gαq/11-
coupled GPCRs can signal downstream to RhoA via a pathway distinct from Gα12/13 and 
independent of the classically described Gαq/11 effector phospholipase C-β [107, 136-139].  
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However, while numerous studies have elucidated mechanisms underlying Gα12/13-
mediated RhoA activation, the signaling pathways which couple Gαq/11 to RhoA activation 
have remained elusive.  
Recently, the Dbl family member p63RhoGEF/GEFT has been described as a novel 
mediator of Gαq/11 signaling to RhoA based on its ability to synergize with Gαq/11 resulting 
in enhanced RhoA signaling (Fig. 5) [152].  Using cell model systems, the authors clearly 
demonstrate that Gαq/11-coupled GPCR activation or overexpression of activated mutants of 
Gαq/11 enhance the ability for overexpressed p63RhoGEF to activate serum response factor 
(SRF)-dependent gene reporters.  Furthermore, using co-immunoprecipitation studies, the 
authors deduced that activated Gαq/11 associates with a C-terminal portion of p63RhoGEF, 
which contains the PH domain, but not the DH domain.   
However, the mechanistic aspects underlying Gαq/11-mediated p63RhoGEF 
activation remain unclear.  In particular, the previous co-immunoprecipitation studies do not 
rule out the indirect association of Gαq/11 with p63RhoGEF through ancillary proteins.  
Therefore, it is necessary to determine whether Gαq/11 can directly modulate the guanine 
nucleotide exchange activity of p63RhoGEF using a defined in vitro system.  Here we report 
using biochemical/biophysical approaches with highly purified protein components to show 
that p63RhoGEF directly and specifically associates with activated Gαq to enhance robustly 
the catalyzed guanine nucleotide exchange of RhoA, RhoB, and RhoC.  Therefore, 
p63RhoGEF is a bona fide effector of Gαq.  Furthermore, these studies strongly implicate 
p63RhoGEF, together with the related Dbl family members, Trio and Kalirin, as a major 
nexus for the activation of RhoA downstream of Gαq/11.   
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Experimental procedures 
Molecular constructs 
Truncation mutant constructs of human p63RhoGEF were PCR-amplified from full-
length human p63RhoGEF (GenBank Accession # BC012860, kindly provided by T. 
Wieland) resulting in the following constructs: DH-Ct (residues 155-580), DH-Ext (residues 
155-493), DH-PH (residues 155-472), and DH (residues 155-347).  PCR products were then 
subcloned into a modified pET-21a vector (Novagen) using a previously published ligation-
independent cloning (LIC) strategy [229].  The bacterial expression vector, pLiC-His-TEV, 
which encodes an N-terminal His6-tag followed by a tobacco etch virus (TEV) cleavage site, 
was used to generate vectors for the DH-Ct, DH-Ext, and DH-PH His6-tagged p63RhoGEF 
constructs.  The p63RhoGEF DH construct was cloned into a His6-tagged, TEV-cleavable, 
maltose-binding protein (MBP) fusion vector (pLiC-His-MBP-TEV) for improved 
expression and solubility.  N-terminal glutathione-S-transferase (GST) tagged constructs for 
p63RhoGEF DH-Ext and DH-PH were cloned into a GST-fusion vector using a similar 
strategy.  Point mutant constructs of p63RhoGEF (F471A, L472A, N473A, L474A, Q476A, 
S477A, P478A, I479A, E480A, Y481A, Q482A, R483A) were generated in the context of 
the His6-tagged DH-Ext using the Quickchange site-directed mutagenesis kit (Stratagene) 
followed by automated sequencing to confirm each mutation.  The coding region for the C-
terminal DH-Ext region of Trio (Trio-C DH-Ext, residues 1291-2299) was PCR amplified 
from full-length human Trio (GenBank Accession # NM_007118, kindly provided by M. 
Strueli) and introduced into the pLiC-His-TEV bacterial expression vector, as described 
above.  Baculovirus for the Gαq and Gα13 chimeras were generously provided by T. Kozasa 
[230, 231].  The ligation-independent cloning strategy was also used to generate mammalian 
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expression constructs for p63RhoGEF full-length, DH-Ext (residues 155-493), and DH-PH 
(residues 155-472), which were subsequently subcloned into a modified N-terminal HA-
tagged pcDNA 3.1 vector.  
 
Protein expression and purification 
All p63RhoGEF and Trio-C recombinant protein expression constructs were 
expressed in the BL21 (DE3) E. coli strain.  Cells were grown up at 37°C in LB media 
containing 0.1 mg/ml ampicillin until an A600 of ~0.6, then induced with 0.1 mM isopropyl-
β-D-thoiogalactopyranoside (IPTG) and grown up at 18°C for ~18 hours.  Cells containing 
His6-tagged proteins were pelleted and resuspended in buffer A consisting of 20 mM Tris 
HCl pH 8.0, 300 mM NaCl, 10% (v/v) glycerol, and 5 mM imidazole.  Resuspended cells 
were lysed using an Emulsiflex C5 homogenizer (Avestin) and lysates were cleared by 
ultracentrifugation.  All proteins were purified using FPLC equipment.  Cleared lysates were 
loaded onto a 5 ml HisTrap Ni2+-affinity column (GE Healthcare) pre-equilibrated in buffer 
A and washed with buffer A and buffer A containing 55 mM imidazole.  His6-tagged proteins 
were then eluted with buffer A containing 400 mM imidazole.  Proteins were additionally 
purified via size-exclusion chromatography using a Sephacryl S-200 column (GE Healthcare) 
pre-equilibrated with buffer B consisting of 20 mM Tris HCl 7.5, 200 mM NaCl, 5% (v/v) 
glycerol, and 2 mM dithiothreitol (DTT).   
Prior to size-exclusion chromatography, some His6-tagged proteins were treated with 
TEV to remove the His6 tag.  Additionally, treatment with TEV allowed for removal of the 
N-terminal MBP-fusion of the p63RhoGEF DH construct.  E. coli cells containing GST-
fusion p63RhoGEF proteins (GST-DH-Ext, GST-DH-PH) were pelleted and resuspended in 
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buffer B, lysed, and centrifuge as above.  Cleared lysates were loaded onto a 5 ml GSTrap 
column (GE Healthcare), washed with buffer B, and eluted with buffer B supplemented with 
10 mM reduced glutathione.  Eluted GST-fusion proteins were subsequently purified via 
size-exclusion chromatography using a Sephacryl S-300 column (GE Healthcare) pre-
equilibrated with buffer B.   
Chimeric fusion constructs of the heterotrimeric G proteins Gαq and Gα13 were 
purified using baculovirus-based expression system (Invitrogen) in High-5 insect cells based 
on methods previously described [230, 231].  Purified protein samples for the heterotrimeric 
G proteins Gαi1, Gαo, Gαt, and Gαs were generously provided by C. Johnston and D. 
Siderovski [232, 233].  Heterotrimeric Gα-subunits were confirmed active using several 
independent methods including AlF4-dependent binding to effectors proteins.  Additionally, 
Dbs DH-PH (residues 623-967), Tiam1 DH-PH (residues 1022-1406), Rac1 (residues 1-189 
C189S), Cdc42 (residues 1-189 C189S), RhoA (residues 1-190 C190S), RhoB (residues 1-
190, C190S), and RhoC (residues 1-191, C191S) were expressed in E. coli and purified 
essentially as previously described [49, 57, 58].   
Size-exclusion chromatography was used for all recombinant protein preparations to 
ensure samples eluted as monodispersed species of correct molecular weight.  All 
recombinant protein concentrations were determined using the A280 method with extinction 
coefficients calculated using the ProtParam tool (ExPASy Molecular Biology Server, [234]), 
analyzed by SDS-PAGE to confirm concentration and ensure purity, flash frozen in liquid 
nitrogen, and subsequently stored at -80°C.   
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Guanine nucleotide exchange assays 
The guanine nucleotide exchange activity of purified RhoGEFs was determined using 
a kinetic, fluorescence-based assay with Rho GTPases that were preloaded with Bodipy 
fluorescein (FL)-conjugated GDP (Bod-GDP, Molecular Probes) essentially as previously 
described [85].  Bod-GDP-preloaded GTPases have a high fluorescence emission; guanine 
nucleotide exchange catalyzed by Dbl family GEFs in the presence of excess unlabeled GDP 
produces a curve that can be fit to an exponential decay equation and solved for an observed 
exchange rate (kobs).  Exchange assays were performed using an LS-55 fluorescence 
spectrometer (PerkinElmer) with wavelengths set at λex = 500 nm (slits = 15 nm), λem = 511 
nm (slits = 5 nm) and quartz cuvettes thermostatted at 20°C while constantly stirred.  
Reactions were carried out in exchange buffer consisting of 20 mM Tris pH 7.5, 200 mM 
NaCl, 10 mM MgCl2, 5% (v/v) glycerol, and 10 µM GDP.  For each exchange assay, Bod-
GDP-preloaded Rho GTPases (200 nM) were allowed to equilibrate in exchange buffer.  
Then 30 µM AlF4 (30 µM AlCl3 + 10 mM NaF) and/or heterotrimeric G proteins at indicated 
concentrations were added.  The presence of AlF4 had no impact on the spontaneous 
exchange rate of Rho GTPases and was used to selectively activate heterotrimeric G proteins 
[86].  Finally, the guanine nucleotide exchange reaction was initiated by the manual addition 
of the 200 nM RhoGEF (or indicated concentrations) and the exchange reaction was 
monitored in real-time until completion.   
The observed exchange rates (kobs) were then calculated for each condition by fitting 
the change in relative fluorescence intensity over time for a given condition to a single-phase 
exponential decay using Prizm data analysis software (GraphPad).  Exchange data depicted 
in bar graphs are the mean and standard deviations for each condition, conducted in triplicate.  
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Representative real-time kinetic exchange data depicted in curves are normalized as follows: 
relative fluorescence units prior to addition of RhoGEF (100% Bod-GDP bound), relative 
fluorescence units at reaction completion (0% Bod-GDP bound).  An alternate version of the 
guanine nucleotide exchange assay was utilized to measure Gαq-mediated stimulation of 
p63RhoGEF in real-time.  This version measured the loading of Bod-GTP onto GDP-bound 
RhoA, essentially as previously described [85], and therefore an increase in fluorescence 
emission is observed.  
 
Analytical size-exclusion chromatography 
Concentrated protein samples were desalted or dialyzed into the indicated S-200 
running buffer at indicated molar ratios and allowed to incubate ~1 hour.  An analytical 24 
ml Sephacryl S-200 size-exclusion column (GE Healthcare) was pre-equilibrated in identical 
S-200 running buffer prior to sample loading.  Sample were loaded onto the size-exclusion 
column and eluted with identical S-200 running buffer following the manufacturer’s protocol 
using an FPLC.  The absorbance at 280 nm was used to determine protein peaks and 0.5 ml 
fractions were collected and subjected to SDS-PAGE analysis followed by Coomassie blue 
staining or silver staining to visualize eluted proteins and/or protein complexes.  Sample 
inputs were also run out on gels to indicate starting samples. 
 
Surface plasmon resonance binding studies 
All surface plasmon resonance (SPR) studies were performed using a Biacore 3000 
instrument (GE Healthcare/Biacore).  An anti-GST antibody was covalently coupled to a 
CM5 Biacore chip per the manufacturer’s protocol.  Binding studies were performed in SPR 
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buffer consisting of 20 mM HEPES pH 7.5, 150 mM NaCl, 10 mM MgCl2, 0.05% (v/v) NP-
40, 100 µM GDP, and 30 µM AlF4 (30 µM AlCl3 + 10 mM NaF).  GST-fusion binding 
surfaces were subsequently generated for individual flow cells by the application of GST-
only, or the GST-tagged p63RhoGEF constructs GST-DH-Ext and GST-DH-PH.  To 
generate SPR-based binding isotherms, an analyte consisting of 10 µM Gαq in AlF4-
containing SPR buffer was flowed over each surface; background binding to the GST-only 
surface was subsequently subtracted from each condition and the corresponding relative units 
(RU) were plotted as a function of time. 
 
Fluorescence polarization binding studies 
A peptide spanning the conserved PH domain extension of p63RhoGEF was 
synthesized and HPLC purified by the Tufts University peptide core facility.  This peptide 
consisted of an N-terminal fluorescein moiety followed by a β-alanine linker and residues 
467-493 of human p63RhoGEF followed by a C-terminal amide group.  Gαq or Gαi1 were 
added at varying concentrations to a 96-well plate containing 5 nM peptide in buffer 
consisting of 20 mM Tris pH 7.5, 200 mM NaCl, 20 mM MgCl2, 0.05% (v/v) NP-40, 30 µM 
GDP, and 30 µM AlF4 (30 µM AlCl3 + 10 mM NaF) with a total volume of 200 µl.  Each 
condition was allowed to equilibrate at 25°C for ~15 min before polarization was determined 
using a PHERAstar fluorescence microplate reader (BMG Labtech) using the polarization 
mode.  The excitation laser (λex = 485 nm) was vertically polarized and the subsequent 
fluorescence emission intensity (λem = 520 nm) was observed through a polarizer orientated 
parallel or perpendicular to the excitation vector.  Polarization (P) was then calculated using 
the formula: P =  (I|| − I⊥)/(I|| + I⊥) where I|| is the intensity of the parallel component and I⊥ is 
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the intensity of the perpendicular component of the emitted light [235].  Peptide in the 
absence of heterotrimeric G protein was used to adjust the gain prior to data collection. 
 
Co-immunoprecipitation studies 
Lipofectomine-2000 reagent (Invitrogen) was used to transfect HEK-293 cells with 
wild-type or activated (Q/L) Gαq in combination with either HA vector control or HA-tagged 
p63RhoGEF (full-length, DH-Ext, or DH-PH) per the manufacturer’s protocol.  Cells were 
lysed 48 hours post-transfection and HA-tagged proteins were immunoprecipitated with an 
anti-HA antibody conjugated to sepharose beads (Roche).  Lysate samples and 
immunoprecipitated proteins were then subjected to SDS-PAGE analysis followed by 
western blotting with antibodies against the HA epitope or against Gαq (Santa Cruz 
Biotechnology). 
 
Results 
Sequence analysis reveals a highly conserved extension of the DH-associated PH domain 
of p63RhoGEF 
Unlike the majority of the 69 human Dbl family GEFs, p63RhoGEF lacks any 
additional signaling domains outside of the canonical DH-PH cassette that defines this 
family.  In order to identify conserved regions that may impart signaling properties or 
suggest modes of regulation for p63RhoGEF, we generated a multiple sequence alignment 
using Clustal-X [236] for eight representative p63RhoGEF orthologs and projected the 
sequence conservation for each residue onto the predicted domain architecture (Fig. 9A).  
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The three-dimensional structure of PH domains is well characterized and takes on an anti-
parallel β-sandwich, consisting of two perpendicular β-sheets, capped by a C-terminal 
amphipathic α-helix, termed αC [61].  Interestingly, the predicted αC helix of p63RhoGEF 
has a highly conserved extension, which is predicted to be unstructured and is not considered 
an integral part of the PH domain based on sequence analysis (Fig. 9B).   
The strict conservation of this region and its proximity to the PH domain led us to 
hypothesize that this unique extension may be essential for regulating the exchange activity 
of p63RhoGEF.  Based on these sequence analysis studies, we generated several p63RhoGEF 
truncation mutant constructs (Fig. 9A) and purified recombinant protein components to near 
homogeneity for use in our subsequent biochemical/biophysical analyses (Fig. 10A). 
 
The guanine nucleotide exchange activity of p63RhoGEF is auto-inhibited by the DH-
associated PH domain 
We tested p63RhoGEF truncation mutants for their ability to promote guanine 
nucleotide exchange using RhoA as a substrate GTPase in order to investigate the 
mechanism of auto-regulation.  The exchange activities of p63RhoGEF constructs 
encompassing the DH-Ct, DH-Ext, and DH-PH were similarly activating towards RhoA, 
yielding an approximately 2─3-fold increase in the exchange rate over the spontaneous 
exchange rate of RhoA alone (Fig. 11).  Additionally, full-length p63RhoGEF was equally 
active (data not shown).  These results rule out possible regulation by inhibitory sequences, 
which have been well characterized for Vav and more recently, Tim family RhoGEFs [73].  
However, under identical conditions, the DH construct was approximately 22-fold more 
active than the spontaneous exchange rate of RhoA alone (Fig. 11), implicating the PH 
domain as a negative regulator of p63RhoGEF exchange activity.  In order to generate 
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soluble p63RhoGEF DH fragment, we used a TEV-cleavable MBP fusion at the N-terminus; 
both MBP-fusion and TEV-treated DH construct retained similar activity toward RhoA.  
Additionally, we used analytical size-exclusion chromatography to show that full-length 
p63RhoGEF binds nucleotide-free RhoA in a sub-stoichiometric manner, further suggesting 
a reduced affinity for substrate Rho GTPase (Fig. 12).  While there is conflicting literature 
regarding the regulatory role of the PH domain of p63RhoGEF, our results are in accordance 
with previous studies that suggest an auto-inhibitory role [146, 149]. 
 
Activated Gαq directly stimulates the guanine nucleotide exchange activity of p63RhoGEF 
While Lutz and colleagues elegantly demonstrated that Gαq/11 synergizes with 
p63RhoGEF to activate RhoA signaling pathways in cells, the authors did not explore the 
underlying mechanism or show that Gαq directly interacts with p63RhoGEF [152].  
Therefore, we used previously published methods [231] to generate soluble recombinant Gαq 
protein in order to test the hypothesis that Gαq directly stimulates p63RhoGEF activity.  The 
Gαi/q chimera generated contains the N-terminal α-helix of Gαi1 followed by TEV cleavage 
site fused to the N-terminus of Gαq; treatment with TEV allows for recovery of nearly full-
length Gαq of high purity (Fig. 10B).  We used purified Gαq to test direct activation of 
p63RhoGEF in real-time using the guanine nucleotide loading assay (Fig. 13).  A portion of 
p63RhoGEF encompassing the DH-Ct was activated by Gαq in an AlF4-dependent manner, 
while the DH-PH fragment was not stimulated.   
We then utilized a kinetic guanine nucleotide exchange assay to quantify Gαq-
mediated activation of several p63RhoGEF truncation mutants (Fig. 14A,B).  The exchange 
activity of each p63RhoGEF truncation mutant construct in the presence of inactive GDP-
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bound Gαq or AlF4 alone was comparable to the control exchange rate, comprising a 2─3-
fold activation over the spontaneous exchange rate of RhoA alone.  However, the DH-Ct and 
DH-Ext constructs of p63RhoGEF were robustly stimulated by AlF4-activated Gαq by 
approximately 26-fold over the spontaneous exchange rate of RhoA alone.  Additionally, 
full-length p63RhoGEF was similarly activated by AlF4-activated Gαq (data not shown).  
Interestingly, the DH-PH construct lacking the conserved extension of the PH domain was 
not stimulated by AlF4-activated Gαq.  This lack of Gαq-mediated stimulation of the DH-PH 
fragment was not simply due to misfolding as the basal activity closely resembled that of the 
DH-Ct and DH-Ext constructs.  Additionally, the DH construct lacking the auto-inhibitory 
PH domain was not further stimulated by addition of AlF4-activated Gαq (Fig. 14C).  Most 
likely, the DH construct represents constitutively active p63RhoGEF.   
The exchange rates catalyzed by p63RhoGEF (DH-Ext) in the presence of increasing 
amounts of AlF4-activated Gαq (Fig. 15A), were used to generate a dose-response curve 
which yielded an EC50 (50% effective concentration) of ~951 nM for the activation of 
p63RhoGEF by AlF4-activated Gαq (Fig. 15B).  Based on these results, the DH-Ext construct 
comprises the minimal region of p63RhoGEF that is both basally auto-inhibited and activated 
by AlF4-activated Gαq; subsequent experiments utilized this DH-Ext construct. 
Next, we identified key residues within p63RhoGEF essential for Gαq-mediated 
activation using site-directed mutagenesis of the conserved PH domain extension (residues 
466-483, alanine 474 was not mutated).  In particular, alanine substitutions in the context of 
DH-Ext at F471, L472, L475, P478, and I479 substantially diminished the capacity for AlF4-
activated Gαq to stimulate the exchange activity of p63RhoGEF compared to wild-type (Fig. 
16A).  The basal exchange activity of these point mutants (i.e., in the absence of activated 
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Gαq) was comparable to the basal exchange activity of wild-type p63RhoGEF and proteins 
eluted as mono-dispersed species of correct molecular weight when analyzed by size-
exclusion chromatography and SDS-PAGE (Fig. 16C), indicating proper folding and protein 
integrity.   
Interestingly, mutations most deleterious to Gαq-mediated stimulation of p63RhoGEF 
display helical periodicity and appear to encompass the single face of an α-helix when 
analyzed using bioinformatics-based methods (ExPASy Molecular Biology Server [234]) 
(Fig. 16B).  This was an unexpected finding as this region is predicted to be unstructured 
based on secondary structure prediction methods.  We therefore performed a limited 
proteolysis digestion of p63RhoGEF DH-PH and DH-CT to show that the region C-terminal 
to the PH domain is largely unstructured, labile, and readily cleaved by the endoproteinase 
Glu-C (Fig. 17).  We hypothesize that this normally disordered extension undergoes a 
conformational change to an α-helix upon binding Gαq.   
We then performed binding assays to determine whether this conserved extension 
was important for directly engaging activated Gαq or merely contributed to allosteric 
activation of the DH domain.  We used both analytical size-exclusion chromatography (Fig. 
18A) as well as SPR analysis (Fig. 18B) to show that the p63RhoGEF DH-Ext binds AlF4-
activated Gαq with a high affinity while the DH-PH construct lacking the extension motif 
does not interact with activated Gαq.  Furthermore, p63RhoGEF DH-Ext could co-
immunoprecipitate activated Gαq when overexpressed in HEK-293 cells, while the DH-PH 
fragment had greatly reduced affinity (Fig. 18C).  Auto-inhibited p63RhoGEF binds 
nucleotide-free RhoA with a relatively low affinity resulting in a sub-stoichiometric 
interaction (Fig. 12).  However, in the presence of AlF4-activated Gαq, p63RhoGEF interacts 
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with RhoA with a stronger affinity as AlF4-activated Gαq can form a stable ternary complex 
with p63RhoGEF (DH-Ct) and nucleotide-free RhoA using analytical size-exclusion 
chromatography (Fig. 19A,B).   
While these results indicate that the C-terminal extension was necessary for binding 
activated Gαq, they do not address whether it was sufficient for binding.  Therefore, we 
generated a peptide corresponding to the C-terminal extension of p63RhoGEF (residues 467-
493) (Fig. 20A) and showed that this peptide was sufficient to bind AlF4-activated Gαq using 
a polarization/anisotropy-based binding assay, while AlF4-activated Gαi did not bind this 
peptide (Fig. 20B).  However, the relatively low affinity for this interaction suggests to us 
that additional regions outside of this minimal peptide are required for full engagement of 
activated Gαq by p63RhoGEF.   
 
G protein specificity determinants for p63RhoGEF 
In order to determine the full spectrum of heterotrimeric G proteins specific for 
p63RhoGEF, we tested a panel of highly purified recombinant Gα-subunits for their ability to 
directly stimulate the exchange activity of p63RhoGEF (Fig. 21A-C).  As expected, the 
exchange activity of p63RhoGEF (DH-Ext) was not affected by the addition of high 
concentrations of AlF4-activated Gαi, Gαo, Gαs, Gαt, and Gα13 (Fig. 21A).  The resulting 
exchange rates were comparable to that of the control exchange rate in the absence of 
heterotrimeric G proteins, comprising a 2─3-fold activation over the spontaneous exchange 
rate of RhoA alone.  Only Gαq robustly stimulated the guanine nucleotide exchange activity 
in an AlF4-dependent manner.  Secondary studies, including AlF4-dependent binding of 
effector proteins, were used to confirm the activity of each heterotrimeric G protein used 
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[232, 233]; the purity and concentration of each heterotrimeric G protein used was 
additionally confirmed using SDS-PAGE analysis (Fig. 21B).  Currently, our group is 
developing baculoviral expression constructs in order to probe additional Gαq family 
members (e.g., Gα11 and Gα14) for activation of p63RhoGEF.   
The substrate Rho GTPase specificity for p63RhoGEF has not been well 
characterized.  Therefore, we investigated the substrate Rho GTPase specificities for Gαq-
activated p63RhoGEF (Fig. 22A-D).  High concentrations of AlF4-activated Gαq in 
combination with p63RhoGEF (DH-Ext) did not promote guanine nucleotide exchange on 
Bod-GDP-preloaded Rac1 (Fig. 22A) or Cdc42 (Fig. 22B).  The activity of both Rac1 and 
Cdc42 were confirmed using the RhoGEFs Tiam1 and Dbs, respectively (Fig. 22A,B).  
Additionally, we demonstrated that Gαq-activated p63RhoGEF catalyzes guanine nucleotide 
exchange on the Rho isozymes RhoB and RhoC (Fig. 22C).  This activation of RhoB and 
RhoC by p63RhoGEF was comparable to that observed with RhoA, implicating p63RhoGEF 
as a Rho isoform-specific exchange factor.  
 
The Rho-specific exchange activity of the C-terminal DH-PH cassette of Trio is similarly 
stimulated by activated Gαq 
Because there is a large precedent for RhoA signaling downstream of Gαq we 
hypothesized additional Dbl family members related to p63RhoGEF may also be directly by 
activated Gαq.  Therefore, we used the basic local alignment search tool (BLAST) [237] in 
order to identify additional proteins homologous to p63RhoGEF that may also interact 
directly with activated Gαq.  We identified the Dbl family proteins Trio and Kalirin as the 
closest paralogs to p63RhoGEF.  More importantly, Trio and Kalirin were the only other 
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proteins that contain the highly conserved C-terminal extension to the PH domain (residues 
471-483), which is required for direct engagement of activated Gαq by p63RhoGEF.  Trio 
and Kalirin are unique in that they are the only Dbl family members that contain two 
independent DH-PH cassettes [55].  The N-terminal DH-PH cassette is Rac1/RhoG-specific, 
while the C-terminal DH-PH cassette is RhoA-specific [238, 239].  Only the C-terminal 
RhoA-specific and not the N-terminal Rac1/RhoG-specific DH-PH cassette of Trio and 
Kalirin bear significant homology to p63RhoGEF (Fig. 23).  Interestingly, residues within 
the PH domain extension which were essential for p63RhoGEF activation by Gαq (F471, 
L472, L475, P478, and I479) are 100% conserved in Trio and Kalirin.   
We subsequently determined that AlF4-activated Gαq can directly stimulate the 
RhoA-specific guanine nucleotide exchange activity of the C-terminal DH-PH cassette of 
Trio (Trio-C DH-Ext) by approximately 2-fold over inactive GDP-bound Gαq or AlF4 alone 
(Fig. 24A,B).  This stimulation by Gαq was not nearly as robust as that seen for p63RhoGEF, 
suggesting that other mechanisms may facilitate the interaction of activated Gαq with Trio.  
Alternatively, Trio-C DH-Ext possesses a higher capacity to catalyze guanine nucleotide 
exchange upon RhoA relative to the equivalent fragment of p63RhoGEF.  Therefore, AlF4-
activated Gαq is stimulating a form of Trio that is already highly exchange-competent such 
that the measured enhancement by Gαq belies the full potential of Gαq to activate full-length 
and, presumably, fully auto-inhibited Trio. 
  
Discussion 
There is considerable evidence suggesting that Gα12/13  and Gαq/11 family members 
independently activate RhoA signaling in response to extracellular stimuli [107, 128, 136-
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139, 227].  While the Gαq/11-specific pathway has remained poorly understood, numerous 
studies indicate that Gα12/13 engage the RGS domain of the p115 family members and 
directly stimulate their RhoA-specific exchange activity [127].  The p115 family RhoGEFs 
are the only Dbl family members that contain an RGS domain; however, previous efforts to 
implicate p115 family members as Gαq/11-responsive RhoGEFs have been largely 
unsuccessful (our unpublished results).  The recent finding that Gαq/11 synergizes with 
p63RhoGEF to promote RhoA signaling in cells was significant given that Gαq-responsive 
RhoGEFs have remained elusive.  However, given that p63RhoGEF lacks any semblance of 
an effector-binding site for activated heterotrimeric G proteins, such as an RGS domain, 
there was no precedent for a direct mode of regulation.  Here we provide evidence that Gαq 
directly engages and stimulates the Dbl family member p63RhoGEF via novel mechanism 
distinct from that previously described for the RGS containing RhoGEFs of the p115 family.   
Like numerous Dbl family members before it, p63RhoGEF was first identified during 
an oncogenic screen based on its ability to robustly transform NIH-3T3 cells [240].  An N-
terminal truncation of p63RhoGEF that most likely arises by alternative splicing has been 
previously described in the literature as GEFT.  GEFT lacks the first 106 amino acids, but is 
nevertheless considered functionally redundant with the full-length protein, p63RhoGEF.  
Previous studies have implicated p63RhoGEF/GEFT in muscle regeneration and myogenesis 
[149], regulation of cardiac sarcomeric actin [147], cell proliferation and migration [148], 
dendritic spine formation [150], and neurite outgrowth [151].  Collectively, these suggest 
p63RhoGEF is an important regulator of actin in excitatory tissues such as muscle and 
neurons.  Interestingly, Gαq-mediated activation of RhoA is also implicated in the 
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pathophysiology of myocardial hypertrophy [102, 103, 105].  Additional studies are needed 
to explore the contribution of p63RhoGEF to these and other physiological responses. 
Our results support previous reports suggesting an auto-inhibitory role for the PH 
domain of p63RhoGEF.  Previous studies have demonstrated that the DH domain of 
p63RhoGEF activated SRF-dependent gene transcription more robustly than full-length 
protein [146].  Previous work has also shown that the PH domain functioned in trans as a 
dominant-negative by reducing SRF-dependent gene transcription mediated by full-length 
[149] or isolated DH domain [146].  However, conflicting reports also suggest the PH 
domain is essential for induction of stress fibers [147]; additional studies may be needed to 
explore the membrane-targeting capacity of the PH domain and other associated in vivo roles.   
We hypothesize that p63RhoGEF is auto-inhibited in a manner analogous to that 
described for Sos1.  The X-ray crystal structure of the Sos1 DH-PH cassette indicates that the 
PH domain folds back onto the DH domain, thereby occluding access to the Rho GTPase 
binding site and inhibiting activity [241].  An extended linker region that joins the adjacent 
DH and PH domains facilitates this intramolecular interaction within Sos1.  However, 
p63RhoGEF bears no significant homology to the regions of Sos1 responsible for 
intramolecular binding.  We are currently attempting to crystallize an auto-inhibited form of 
p63RhoGEF in order to better understand the molecular requirements of auto-inhibition 
mediated by the DH-associate PH domain. 
Our results clarify conflicting literature regarding the Rho GTPase substrate 
specificity of p63RhoGEF.  Previous reports suggest that p63RhoGEF is specific for RhoA in 
REF52 fibroblasts [147], H9C2 cardiomyocytes [147], J82 epithelial cells [146], and HEK-
293 cells [146, 152].  Yet, other studies also characterized p63RhoGEF as specific for 
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Rac1/Cdc42 in Cos-7 and HeLa cells [148] or promiscuous for RhoA/Rac1/Cdc42 in C2C12 
muscle cells [149] and N2A neuroblastoma cells [150, 151].  A high degree of crosstalk 
within the Rho subfamily typically complicates the interpretation of these cell-based 
specificity studies.  Furthermore, previous in vitro analysis of p63RhoGEF specificity have 
relied on sub-optimal methodology and have produced results suggesting either RhoA [146, 
147] or Rac1/Cdc42 specificity [148].  Therefore, we performed in vitro characterization of 
substrate Rho GTPases using highly purified components with a robust real-time assay [85] 
to demonstrate that p63RhoGEF specifically activates the Rho isozymes RhoA, RhoB, and 
RhoC with similar potency.  This result is in accordance with studies demonstrating the 
specific activation of RhoA, and not Rac1 or Cdc42, downstream of Gαq/11 [107, 128, 136-
139, 227].  While the three Rho isozymes are highly homologous, recent evidence suggests 
they are not functionally redundant [51]; additional studies are required to determine the 
functional relevance of RhoB/RhoC activation downstream of Gαq/11 and p63RhoGEF.  
Interestingly, the p63RhoGEF gene, GEFT, bears the official moniker RAC/CDC42 
EXCHANGE FACTOR; our studies indicate this is a misnomer. 
Based on sequence similarity, strict conservation of the PH domain extension, and 
evidence that Trio-C is directly stimulated by activated Gαq we hypothesize that 
p63RhoGEF, Trio, and Kalirin represent a novel subset of Dbl family RhoGEFs regulated by 
Gαq/11.  Trio and Kalirin share remarkable similarity with each other in their domain 
architecture and Trio-like proteins are highly conserved evolutionarily [242, 243].  Trio and 
Kalirin are essential regulators of axon guidance and neuronal cell migration during neuronal 
development.  A majority of studies on Trio and Kalirin have focused on the N-terminal 
Rac1/RhoG-specific DH-PH cassette; little is known about the C-terminal RhoA-specific 
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DH-PH cassette.  There is no current evidence implicating Trio and Kalirin in Gαq/11-
mediated signaling pathways, although future studies may lend credence to this intriguing 
possibility. 
In summary, the studies presented here uncover a novel mode of regulation for Dbl 
family GEFs by heterotrimeric G proteins and suggests that, in addition to p63RhoGEF, 
Kalirin and Trio may also signal downstream of Gαq/11 (Fig. 25).  Now, p63RhoGEF joins a 
small group of Dbl family members that have been shown to be directly activated by 
heterotrimeric signaling components (Fig. 26).  Ongoing crystallographic studies within our 
group should soon uncover the molecular details underlying p63RhoGEF activation by Gαq 
at atomic resolution. 
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Figure 9: Sequence analysis of p63RhoGEF. 
(A) A multiple sequence alignment for p63RhoGEF was generated from eight different species and 
used to calculate the percent identity for each residue; these values are depicted as a bar graph 
projected onto the domain architecture of p63RhoGEF. (B) The detailed portion of the multiple 
sequence alignment (spanning residues 443-499 of human p63RhoGEF) highlights a conserved 
extension to the C-terminal αC helix of the PH domain. Also shown is the predicted secondary 
structure for this region comprising the β7 β-sheet, αC α-helix, and unstructured regions depicted as a 
black line; truncation mutants generated for this study are also shown at top of (A) with construct 
borders in parentheses. 
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Figure 10: Purified protein components used for characterization of p63RhoGEF. 
(A,B) Equal amounts (~5 µg) of purified protein components, including p63RhoGEF truncation 
constructs (A) and recombinant Gαq (B) were analyzed by SDS-PAGE and stained with Coomassie 
blue to confirm purity and concentration; molecular weight standards are also shown. 
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Figure 11: The PH domain negatively regulates the exchange activity of p63RhoGEF. 
RhoA alone, spontaneous nucleotide exchange of 200 nM Bod-GDP-preloaded RhoA in the absence 
of p63RhoGEF; all others, 200 nM of the indicated p63RhoGEF truncation mutant was added to 200 
nM Bod-GDP-preloaded RhoA in order to initiate guanine nucleotide exchange. Also shown is the 
calculated fold-activation over RhoA alone for each construct, all curves are representative of 
experiments performed in triplicate.  
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Figure 12: Auto-inhibited p63RhoGEF has reduced affinity for nucleotide-depleted RhoA. 
(A,B) Analytical size-exclusion chromatography was used in the presence of EDTA to isolate a 
heterodimeric complex consisting of p63RhoGEF (full-length) and nucleotide-depleted RhoA. (A) 
Chromatogram depicting absorption peaks for p63RhoGEF with RhoA at a 1:2 molar ratio (solid 
black line) or RhoA alone (dashed gray line). (B) Indicated fractions from (A) were subjected to SDS-
PAGE analysis followed by staining with Coomassie blue indicating a sub-stoichiometric interaction; 
also shown are molecular weight standards and protein input sample. 
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Figure 13: Gαq stimulation of p63RhoGEF in real-time. 
(A,B) The guanine nucleotide exchange assay was used to monitor the loading of 500 nM Bod-GDP 
onto 2 µM RhoA catalyzed by 200 nM of the indicated p63RhoGEF construct; at time points 
indicated by arrows 30 µM AlF4, 2 µM Gαq, or 200 nM p63RhoGEF (DH-Ct) were manually injected 
into the indicated reaction mixture. Maximal guanine nucleotide loading was only observed when 
p63RhoGEF (DH-Ct), Gαq, and AlF4 were all present. 
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Figure 14: Gαq directly stimulates the exchange potential of p63RhoGEF. 
(A) RhoA alone, spontaneous nucleotide exchange of RhoA in the absence of p63RhoGEF; all others, 
200 nM of the indicated p63RhoGEF truncation mutant was added to 200 nM Bod-GDP-preloaded 
RhoA in the presence or absence of 30 µM AlF4 and 200 nM Gαq. Bar graphs depict the mean and 
standard deviation for each condition conducted in triplicate. (B) Representative real-time kinetic data 
for the DH-Ext construct used to calculate exchange rates. (C) The exchange activity of 200nM 
p63RhoGEF DH upon 200 nM Bod-GDP-preloaded RhoA in the presence and absence of 200 nM 
AlF4-actived Gαq; shown is the mean and standard deviation, n.s., not significant by pairwise t-test. 
 
 
 
 
 
 74
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15: Dose-response curve for Gαq-mediated stimulation of p63RhoGEF. 
(A) The guanine nucleotide exchange activity of 200 nM p63RhoGEF (DH-Ext) upon 200 nM Bod-
GDP-preloaded RhoA was determined in the presence of increasing amounts of AlF4-activated Gαq 
(6.25 nM to 5 µM); shown are representative traces for each concentration used. (B) The calculated 
exchange rates (kobs) were plotted against Gαq concentration and fit to a one-site binding curve; data 
are the mean and standard deviation of two independent experiments. 
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Figure 16: Mutational analysis of the conserved PH domain extension within p63RhoGEF.  
(A) Alanine substitutions were made within the conserved PH domain extension of p63RhoGEF in 
the context of DH-Ext. 200 nM of each point mutant was added to 200 nM Bod-GDP-preloaded 
RhoA in the presence of 300 nM Gαq and 30 µM AlF4 prior to measuring exchange rates; the 
exchange activity of 200 nM wild-type (wt) p63RhoGEF (DH-Ext) in the presence and absence of 
300 nM Gαq and 30 µM AlF4 is also shown. Bar graphs depict the mean and standard deviation for 
the calculated exchange rate of each condition, conducted in triplicate; the most deleterious point 
mutants are highlighted. (B) Sequence containing the conserved PH domain extension (residues 466-
483, ESQRDFLNALQSPIEYQR) was modeled as an α-helix and displayed as a helical wheel 
(ExPASy Molecular Biology Server) with the corresponding residue numbers, highlighted is the 
region predicted to bind Gαq. (C) Equal amounts (~10 µg) of purified p63RhoGEF point mutants 
used in (A) were analyzed by SDS-PAGE and stained with Coomassie blue to confirm purity and 
concentration; molecular weight standards are also shown (note that alanine 474 was not mutated). 
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Figure 17: Limited proteolysis of p63RhoGEF fragments.  
Purified samples of p63RhoGEF DH-PH and DH-Ct were digested with endoproteinase Glu-C, which 
cleaves C-terminal to glutamic acid residues, for increasing amounts of time and then analyzed by 
SDS-PAGE. The DH-PH fragment is extremely stable, while the region C-terminal to the PH domain 
is labile and readily cleaved. 
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Figure 18: The conserved PH domain extension of p63RhoGEF is essential for direct binding of 
activated Gαq. 
(A) Analytical gel-exclusion chromatography was used to isolate a heterodimeric complex of AlF4-
activated Gαq with GST-tagged p63RhoGEF (GST-DH-Ext); under identical conditions the GST-
DH-PH construct did not complex with AlF4-activated Gαq (lower panel). (B) GST-tagged 
p63RhoGEF truncation constructs (GST-DH-Ext and GST-DH-PH) were immobilized onto the 
surface of Biacore chip; analyte consisting of 10 µM AlF4-activated Gαq was then flowed over each 
surface while measuring surface plasmon resonance. (C) Activated Gαq (Q/L) was co-
immunoprecipitated with HA-tagged p63RhoGEF in HEK-293T cells as described in experimental 
procedures. 
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Figure 19: Formation of stable heterotrimeric complex of p63RhoGEF, AlF4-activated Gαq, 
and nucleotide-depleted RhoA. 
(A,B) Analytical size-exclusion chromatography was used in the presence of AlF4 to isolate a 
heterotrimeric complex consisting of p63RhoGEF (DH-Ct), AlF4-activated Gαq, and nucleotide-
depleted RhoA. (A) Chromatogram depicting absorption peaks for p63RhoGEF/Gαq/RhoA at a 1:1:2 
molar ratio (solid red line), p63RhoGEF alone (dashed black line), or Gαq alone (dashed gray line). 
(B) Indicated fractions from (A) were subjected to SDS-PAGE analysis followed by staining with 
Coomassie blue; also shown are molecular weight standards and protein input sample. 
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Figure 20: A peptide encompassing the conserved PH domain extension of p63RhoGEF directly 
binds activated Gαq. 
(A) A fluorophore-conjugated peptide corresponding to the conserved PH domain extension of 
human p63RhoGEF (residues 467-493) was generated and used in a  polarization/anisotropy  assay 
(B) to show direct dose-dependent binding to AlF4-activated Gαq, as described in experimental 
procedures. 
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Figure 21: Specificity of p63RhoGEF for heterotrimeric Gα-subunits.   
(A) 200 nM p63RhoGEF (DH-Ext) was added to reaction mixtures containing 200 nM Bod-GDP-
preloaded RhoA in the presence or absence of 30 µM AlF4 and 500 nM of the indicated Gα-subunit 
(Gαq, Gαi, Gαo, Gαs, Gαt, Gα13). (B) Equal amounts (~5 µg) of purified heterotrimeric G-protein 
components used in (A) were analyzed by SDS-PAGE and stained with Coomassie blue to confirm 
purity and concentration; molecular weight standards are also shown. (C) Phylogenetic tree 
representing heterotrimeric Gα-subunit sequence conservation, representative proteins used in (A) are 
bold.  
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Figure 22: Specificity of p63RhoGEF for Rho GTPases.   
(A,B) 500 nM p63RhoGEF (DH-Ext), 500 nM Gαq, and 30 µM AlF4 were added to reaction mixtures 
containing 200 nM Bod-GDP-preloaded Rac1 (A) and Cdc42 (B). 500 nM Tiam1 (DH-PH) was 
added to (A) and 50 nM Dbs (DH-PH) was added to (B) to confirm Rac1 and Cdc42 activity, 
respectively. (C) RhoB alone, RhoC alone, spontaneous nucleotide exchange in the absence of 
p63RhoGEF; all others, 200 nM p63RhoGEF (DH-Ext) was added to reaction mixtures containing 
200 nM Bod-GDP-preloaded RhoB or RhoC in the presence or absence of 30 µM AlF4 and 200 nM 
Gαq. Bar graphs depict the mean and standard deviation for the calculated exchange rate (kobs) of 
each condition, conducted in triplicate. (D) Phylogenetic tree representing Rho subfamily GTPase 
sequence conservation, representative proteins used in (A-C) are bold.  
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Figure 23: Sequence conservation among the PH domain extensions of p63RhoGEF, Trio, and 
Kalirin. 
Domain architecture of p63RhoGEF and its closest paralogs, Trio and Kalirin and multiple sequence 
alignment of the highly conserved C-terminal extension of the PH domain (red); also shown is the 
predicted secondary structure for the region of the PH domain proximal to the extension motif (β7, β-
sheet; αC, C-terminal α-helix; black line, unstructured). 
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Figure 24: Gαq directly stimulates the guanine nucleotide exchange activity of Trio-C. 
(A) The guanine nucleotide exchange assay was used to determine the exchange potential (kobs) of 
Trio in response to AlF4-activated Gαq. RhoA alone, spontaneous nucleotide exchange for 200 nM 
Bod-GDP-loaded RhoA in the absence of Trio-C; all others, 200 nM of Trio-C (DH-Ext) was added 
to 200 nM Bod-GDP-preloaded RhoA in the presence or absence of 30 µM AlF4 and 2 µM Gαq as 
indicated. Bar graphs depict the mean and standard deviation for the calculated exchange rate (kobs) of 
each condition, conducted in triplicate, * denotes p < 0.02 compared to no Gαq/AlF4 present by 
pairwise t-test. (B) Representative real-time kinetic data used to calculate exchange rates in (A). 
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Figure 25: Proposed model for p63RhoGEF activation by Gαq. 
Basally, p63RhoGEF exists in an auto-inhibited conformation with the DH-associated PH domain 
occluding access to the GTPase binding site within the DH domain. Activated Gαq/11 family 
members directly engage p63RhoGEF via a conserved extension to the PH domain (Ext), thereby 
relieving auto-inhibition and allowing robust activation of Rho isozymes.   
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Figure 26: Dbl family RhoGEFs directly activated by heterotrimeric G-proteins. 
The exchange factors p63RhoGEF, p115RhoGEF, and P-Rex comprise a small group of Dbl family 
members, which are directly activated by heterotrimeric G-proteins, via distinct mechanisms. 
 
 
 
 CHAPTER 3: SMGGDS IS AN ATYPICAL ARMADILLO REPEAT-CONTAINING 
EXCHANGE FACTOR FOR RHO 
Background 
The Ras superfamily is composed of over 150 members which make up the Ras, Rho, 
Ran, Rab, Arf, and Rem/Rad subfamilies [36].  These monomeric GTPases of ~21 kDa are 
essential for a variety of biological phenomenon and regulate a plethora of signaling cascades 
downstream of extracellular stimuli.  Each subfamily is grouped based upon sequence 
homology; each sharing common structural features, such as conserved insertions, which 
define the subfamily and impart signaling specificity.  All GTPases function as binary 
switches dependent upon bound nucleotide, existing in discrete GTP-bound “on” and GDP-
bound “off” conformations [2].   
The cycling between active and inactive states is tightly regulated by two classes of 
proteins: guanine nucleotide exchange factors (GEFs) and GTPase accelerating proteins 
(GAPs).  GEFs activate GTPases by promoting the release of bound nucleotide.  The 
intracellular concentration of GTP greatly exceeds that of GDP; therefore, GEFs catalyze the 
exchange of bound GDP for GTP.  GAPs function to greatly accelerate the slow intrinsic rate 
of GTP hydrolysis, thereby inactivating the GTPase.  Conformationally flexible switch 
regions within Ras superfamily GTPases are sensitive to bound nucleotide and make up the 
majority of binding interface between regulatory proteins and downstream effectors.  The 
crystal structures of numerous Ras superfamily GTPases have been solved both in apo forms 
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and bound to GEFs, GAP, and effectors, allowing unprecedented insight into the molecular 
mechanisms underlying guanine nucleotide exchange, GTP hydrolysis, and effector coupling.   
GEFs and GAPs specific for individual subfamilies of Ras GTPases are structurally 
unique and display selectivity within a single subfamily.  For example, GEFs specific for Ras 
GTPases (Ras-GEFs) are structurally defined by the presence of a conserved CDC25/REM 
domain, while GEFs specific for Rho GTPases (RhoGEFs) share a conserved Dbl homology 
(DH) domain.  Moreover, Ras-GEFs and Dbl family RhoGEFs bear no significant sequence 
or structural homology to each other or to GEFs specific for other subfamilies, such as Arf 
[244] and Ran [245].  
While the vast majority of exchange factors for Rho GTPases are Dbl family 
members [55], there is a subset of RhoGEFs which do not share sequence homology to the 
Dbl family GEFs; these proteins are termed atypical or non-conventional RhoGEFs.  
Atypical RhoGEFs currently described in the literature include the bacterial toxin SopE 
[153], the CZH family proteins, including the related Zizimin-like and Dock180-like proteins 
[155], the phospholipid-binding protein SWAP-70 [157, 158], and the armadillo repeat-
containing protein SmgGDS (Fig. 27).  These various atypical RhoGEFs lack any global or 
local sequence similarity and are each unique in their overall domain composition (Fig. 6).   
The mechanism by which atypical RhoGEFs engage their target GTPase substrates 
remains poorly defined.  However, a direct comparison between the crystal structures of the 
Dbl family member Dbs [58] and the bacterial toxin SopE [153] reveals that both GEFs 
engage the switch regions of nucleotide-free Cdc42 in identical conformations.  We 
hypothesize that other atypical RhoGEFs most likely also engage the switch regions of 
nucleotide-free GTPases in a manner similar to that typified by Dbl family GEFs.  Yet, 
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because these proteins are highly unrelated to each other or Dbl family GEFs, they must 
display distinct binding surfaces in order to engage the appropriate Rho subfamily member.   
Unique among those already labeled as “atypical” is the armadillo repeat (ARM)-
containing protein SmgGDS, as it is reported to non-selectively act as a GEF for both Ras 
and Rho GTPases (Fig. 28).  SmgGDS has a checkered past, since its discovery in 1990 
[169] it has been characterized as an exchange factor for varying combinations of the 
following GTPases: RhoA [169, 173, 174, 176, 179, 189, 190, 192, 193], RhoB [169, 174], 
Rac1 [178-180, 189, 190], Rac2 [178, 190, 191], Cdc42 [190], K-Ras [174, 179], Rap1A 
[170, 179, 190], and Rap1B [170-172, 174, 175, 177, 184, 185].  SmgGDS is a highly 
conserved protein (Fig. 29), and deletion of SmgGDS in mice results in post-natal lethality 
[208].  Evidence suggests that in the physiological context of a cell SmgGDS promotes cell 
growth [207-211] and has been found as a chromosomal rearrangement partner in a subset of 
leukemias [213-215].  Emerging data also suggest that SmgGDS may play a role in the 
cytoplasmic-nuclear shuttling of Rac and Rho isozymes [202, 206] or modulate the activity 
of the Dbl family member β-Pix [200].   
While a majority of the previous biochemical studies utilized sub-optimal 
methodology and protein components to determine the substrate specificities of SmgGDS, 
there have been some striking commonalities among the early characterizations of SmgGDS.  
For example, the preferred small GTPase substrate has consistently been described as RhoA 
[174, 179, 189, 190, 192, 193, 201, 202, 206] and the C-terminal polybasic region of the 
target substrate GTPase has been described as a major contributor to SmgGDS binding [202, 
206].  This suggested to us that SmgGDS is actually a Rho-specific exchange factor that was 
previously mischaracterized primarily due to the lack of rigorous in vitro biochemical 
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methodologies.  Therefore, we sought to utilize highly purified recombinant protein 
components and highly robust, real-time fluorescence-based methods to determine whether 
SmgGDS is an exchange factor selective for Rho GTPases.   
Here we describe an in depth analysis of the target GTPase substrate specificity of 
SmgGDS and demonstrate unequivocally that SmgGDS is a Rho-specific exchange factor 
that does not activate Ras-related GTPases.  Moreover, we demonstrate that SmgGDS 
engages target substrates via their C-terminal polybasic region (PBR), a mechanism that is 
unique among Rho exchange factors.  We also describe the preliminary crystallization of a 
dimeric complex of SmgGDS bound to nucleotide-free RhoA.  This report is the first of its 
kind to characterize the substrate selectivity of SmgGDS using a large panel of recombinant 
Ras superfamily GTPases.  Furthermore, the initial crystallization of SmgGDS bound to 
nucleotide-free RhoA takes us one step closer to understanding, at atomic resolution, the 
molecular mechanism by which this atypical RhoGEF catalyzes guanine nucleotide 
exchange. 
 
Experimental procedures 
Molecular constructs 
Bacterial expression constructs of SmgGDS were PCR-amplified from full-length 
bovine SmgGDS (kindly provided by L. Quilliam) resulting the truncation mutant constructs 
encompassing the following residues: 1-558, 1-494, 19-494, 19-472, 75-494, 75-558, 1-472.  
These constructs represent the short isoform of SmgGDS and therefore lack ARM-2A.  Full-
length human SmgGDS representing the long isoform, which retains the ARM-2A, was also 
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PCR-amplified from a human cDNA clone (IMAGE Consortium).  PCR products were then 
subcloned into a modified pET-21a vector (Novagen) using a previously published ligation-
independent cloning (LIC) strategy [229].  The bacterial expression vector, pLiC-His-TEV, 
which encodes an N-terminal His6-tag followed by a TEV cleavage site, was used to generate 
expression vectors for all SmgGDS constructs, both bovine and human.  Ras superfamily 
GTPases were similarly cloned into bacterial expression vectors, as previously described, 
[29, 49, 57, 58].  All full-length GTPase coding regions deleted the C-terminal CAAX motif, 
if present, and additionally mutated the terminal cysteine residue to a non-reactive serine, to 
aid protein stability and solubility.  This resulted in the following constructs: RhoA, RhoB, 
RhoC, Rac1, Rac2, Cdc42, TC10, TCL, Rnd3, RhoD, RhoG, H-Ras, Rap1A, Ral-A, and Ral-
B [29].  Truncation mutants which deleted the C-terminal polybasic region (∆PBR) were 
generated using a similar strategy for RhoA, RhoB, and Rac1, thereby yielding RhoA 
(∆PBR), RhoB (∆PBR), and Rac1 (∆PBR). 
 
Protein expression and purification 
All SmgGDS and Ras superfamily recombinant protein expression constructs were 
expressed in the BL21 (DE3) E. coli strain.  Cells were grown up at 37°C in LB media 
containing 0.1 mg/ml ampicillin until an A600 of ~0.6, then induced with 0.1-0.5 mM IPTG 
and grown up at 18°C for ~18 hrs.  Cells containing His6-tagged SmgGDS constructs were 
pelleted and resuspended in buffer A consisting of 20 mM Tris HCl pH 8.0, 300 mM NaCl, 
10% (v/v) glycerol, and 5 mM imidazole.  Resuspended cells were lysed using an Emulsiflex 
C5 homogenizer (Avestin) and lysates were cleared by ultracentrifugation.  All proteins were 
purified using FPLC methods.  Cleared lysates were loaded onto a 5 ml HisTrap Ni2+-affinity 
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column (GE Healthcare) pre-equilibrated in buffer A, washed first with buffer A and then 
with buffer A containing 55 mM imidazole.  His6-tagged proteins were then eluted with 
buffer A containing 400 mM imidazole.  Proteins were additionally purified via size-
exclusion chromatography using a Sephacryl S-200 column (GE Healthcare) pre-equilibrated 
with buffer B consisting of 20 mM Tris HCl 8.0, 300 mM NaCl, 5% (v/v) glycerol, and 2 
mM DTT.  His6-tagged GTPases were purified in a similar fashion to SmgGDS constructs, 
however all GTPase buffers were supplemented with 5 mM MgCl2 and 30 µM GDP, 
essentially as previously described [49, 57, 58].  Prior to size-exclusion chromatography, 
some His6-tagged proteins were treated with TEV to remove the His6 tag.  Additionally, Dbs 
DH-PH (residues 623-967), Tiam1 DH-PH (residues 1022-1406), and the CDC25/REM 
domain of Sos1 were expressed in E. coli and purified using Ni2+-affinity chromatography 
and size-exclusion chromatography essentially as previously described [49, 57, 58, 246].  
Size-exclusion chromatography was used as a final step for all recombinant protein 
preparations to ensure samples eluted as monodispersed species of correct molecular weight.  
All recombinant protein concentrations were determined using the A280 method with 
extinction coefficients calculated using the ProtParam tool (ExPASy Molecular Biology 
Server, [234]), analyzed by SDS-PAGE to confirm concentration and ensure purity, flash 
frozen in liquid nitrogen, and subsequently stored at -80°C.   
 
Guanine nucleotide exchange assays 
The guanine nucleotide exchange activity of SmgGDS was determined using a 
loading assay with Bodipy Texas Red (TR)-conjugated GTP (Bod-GTP, Molecular Probes) 
essentially as previously described [85].  Exchange assays were performed using an LS-55 
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fluorescence spectrometer (PerkinElmer) with wavelengths set at λex = 580 nm (slits = 5 nm), 
λem = 630 nm (slits = 5 nm) and quartz cuvettes thermostatted at 20°C while constantly 
stirred.  Reactions were carried out in exchange buffer consisting of 20 mM Tris pH 7.5, 200 
mM NaCl, 10 mM MgCl2, and 5% (v/v) glycerol.  For each exchange assay, ~2 µM of the 
indicated Ras superfamily GTPase was allowed to equilibrate in exchange buffer containing 
500 nM Bod-GTP.  Subsequently, the indicated amount of SmgGDS or positive control 
exchange factor was added to the reaction mixture to initiate guanine nucleotide exchange.  
The baseline value of relative fluorescence units (RFU) prior to addition of exchange factor 
was subtracted for each assay performed in order to plot each curve in a consistent manner.  
Plotted curves for each guanine nucleotide exchange assay are representative of experiments 
conducted in triplicate.       
 
Analytical size-exclusion chromatography 
Running buffers for nucleotide-free conditions consisted of buffer B supplemented 
with 5 mM EDTA; GDP conditions consisted of buffer B supplemented with 2 mM MgCl2 
and 30 µM GDP; GTPγS conditions consisted of buffer B supplemented with 2 mM MgCl2 
and 30 µM GTPγS.  Concentrated protein samples were desalted or dialyzed into the 
indicated running buffer at a molar ratio of 1:2 (SmgGDS:GTPase) and allowed to incubate 
~30 minutes prior to application.  An analytical 24 ml Sephacryl S-200 size-exclusion 
column (GE Healthcare) was pre-equilibrated in identical analytical S-200 running buffer 
prior to sample loading.  Samples were loaded onto the size-exclusion column and eluted 
with identical S-200 running buffer following the manufacturer’s protocol using an FPLC.  
The absorbance at 280 nm was used to determine protein peaks and 0.5 ml fractions were 
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collected and subjected to SDS-PAGE analysis followed by Coomassie blue staining to 
visualize eluted proteins and/or protein complexes.  Sample inputs were also run on gels to 
indicate starting samples and confirm eluted protein complexes.  All figures illustrating 
analytical size-exclusion chromatography results share a similar labeling scheme; 
volume/fraction are depicted increasing left to the right, with larger proteins and protein 
complexes eluting first (left side) and smaller proteins eluting later (right side).  When 
possible, identical fractions/volumes are shown for direct comparison.  Void volume 
fractions, which contain higher-order protein aggregates and high molecular weight 
complexes, were not included in figures. 
 
Limited proteolysis digestion 
The Peptide Mapping Set (Roche) was used to determine labile and unstructured 
regions of several SmgGDS clones per the manufacturer’s protocol.  Briefly, SmgGDS 
constructs were incubated with sequencing grade Trypsin in buffer consisting of 100 mM 
Tris HCl pH 8.5, at several time points (0, 5, 15, 30, 60 minutes) equal volume samples were 
removed, added to Laemmli buffer, and immediately boiled at 100°C.  Protein samples were 
then analyzed by SDS-PAGE and stained with Coomassie blue.   
  
Crystallization of SmgGDS-RhoA 
A heterodimeric complex of bovine SmgGDS (1-472) bound to nucleotide-free RhoA 
(FL) was formed by gel-exclusion chromatography.  A 1:2 molar ratio of SmgGDS:RhoA 
was dialyzed in buffer B supplemented with 5 mM EDTA and concentrated to a volume of 
~5 ml.  Sample was then applied to a 200 ml Sephacryl S-200 column (GE Healthcare) pre-
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equilibrated with buffer B containing 5 mM EDTA.  Fractions containing a 1:1 complex 
were pooled, concentrated, flash-frozen in liquid nitrogen, and stored at -80°C for future use.  
Several commercially available crystal screening kits (Nextal/Qiagen) were used during the 
crystal screening process.  Protein crystals were formed in sitting drops using vapor 
diffusion.  Drops were formed by combining equal volumes (2 µl each) of concentrated 
protein sample at ~15 mg/ml with reservoir solution and then equilibrated against 0.5 ml 
reservoir solution at 18°C.  Several crystallization conditions yielded protein crystals 
including: 100 mM Tris HCl pH 7.5, 20% (v/v) Jeffamine M600, 200 mM CaCl2; 100 mM 
HEPES pH 7.5, 25% (v/v) PEG 400, 200 mM MgCl2. 
 
Results 
SmgGDS is an exchange factor for Rho 
In order to determine whether recombinant SmgGDS functions as an exchange factor, 
we first purified recombinant protein components for use in a fluorescence-based real-time 
guanine nucleotide exchange assay.  Full-length bovine SmgGDS was produced and used to 
demonstrate exchange activity toward Rho isozymes (Fig. 30A-C).  Addition of SmgGDS to 
full-length RhoA (Fig. 30A) significantly stimulated the exchange rate over that of the 
spontaneous exchange rate.  Addition of SmgGDS to full-length RhoB (Fig. 30B) had a less 
robust effect on guanine nucleotide exchange, while addition of SmgGDS to full-length 
RhoC (Fig. 30C) did not affect the guanine nucleotide exchange rate.  Use of positive 
controls for each GTPase confirmed that proteins were functional and exchange-competent.  
The activity of SmgGDS toward RhoA was highly reproducible in a number of assay formats 
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and concentration-dependent (data not shown).  The activity of SmgGDS towards RhoB was 
less robust and was shown to be highly dependent upon the spontaneous exchange rate of 
RhoB alone, which was determined to be exceedingly high.  These results indicated to us that 
SmgGDS preferentially activates RhoA over RhoB and RhoC.   
The relative concentration of SmgGDS required to elicit guanine nucleotide exchange 
upon RhoA was empirically determined to be ~10 µM, which was surprisingly high 
compared to previously-characterized Dbl family GEFs.  For example, 500 nM of the Dbl 
family GEF, Dbs, can robustly activate 2 µM of RhoA using the same assay format (Fig. 
30A, inset).  However, in order for SmgGDS to elicit a similar level of activity toward 2 µM 
RhoA, the concentration must be upwards of ~10 µM, which encompasses ~20-fold 
difference over that of Dbs (Fig. 30A).  This discrepancy between the activities of SmgGDS 
and Dbs indicates that SmgGDS is an inefficient exchange factor; we took this into account 
when characterizing other potential target GTPase substrates of SmgGDS.  We subsequently 
determined that high concentrations (~20-40 µM) of SmgGDS are insufficient to exchange 
guanine nucleotide on Rac1 isozymes (Fig. 31A), Cdc42-related GTPases (Fig. 31B), or 
various Ras-related GTPases (Fig. 31C).  We additionally tested the Rho subfamily members 
Rnd3, RhoG, and RhoD and determined that these too were not activated by SmgGDS at 
high concentration (data not shown).  These results are in direct contrast to previous reports 
implying that SmgGDS is a GEF for numerous Ras and Rho subfamily GTPases.   
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SmgGDS binds preferentially to the nucleotide-free state of RhoA and Rac1 via the C-
terminus 
We performed analytical size-exclusion chromatography-based binding assays in 
order to establish whether SmgGDS discriminates between the various nucleotide-bound 
states of GTPases and to better understand the binding mechanisms involved.  SmgGDS 
forms a stable dimeric complex at an apparent 1:1 molar ratio with nucleotide-free full-length 
RhoA (Fig. 32, top panel) and nucleotide-free full-length RhoB (Fig. 34, right panel).  
However, GDP- or GTPγS-bound RhoA did not bind SmgGDS (Fig. 32, middle panel), nor 
did nucleotide-free full-length Cdc42 and RhoC (Fig. 34, left panel).  Interestingly, the C-
terminal polybasic region (PBR) of RhoA was critical for binding, as nucleotide-free RhoA 
(∆PBR) has a much lower affinity for SmgGDS, resulting in minimal complex formation 
(Fig. 32 bottom panel).  We next tested whether SmgGDS retains guanine nucleotide 
exchange activity towards the C-terminal truncation mutants RhoA (∆PBR) and RhoB 
(∆PBR).  Deletion of the C-terminal PBR drastically reduced the capacity for SmgGDS to 
stimulate guanine nucleotide exchange upon RhoA (∆PBR) (Fig. 30D) and RhoB (∆PBR) 
(Fig. 30E).   
Several recent reports indicate that SmgGDS may play a role in mediating the 
cytosolic-nuclear shuttling of Rac1 [202, 206].  Using co-immunoprecipitation studies, these 
reports show convincing data indicating that SmgGDS binds Rac1 preferentially in the 
nucleotide-free state dependent upon the C-terminal PBR [202, 206].  We therefore used 
analytical size-exclusion chromatography to demonstrate that SmgGDS interacts with Rac1 
preferentially in the nucleotide-free state, dependent upon the C-terminal PBR (Fig. 33).  
However, we could not detect any guanine nucleotide exchange activity towards either full-
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length Rac1 (Fig. 31A) or Rac1 (∆PBR) using several different formats of the guanine 
nucleotide exchange assay (data not shown).  This seemingly contradictory result suggests to 
us that SmgGDS engages Rac1 in a manner distinct from RhoA, lending credence to a unique 
nuclear shuttling activity upon Rac1 [202, 206].   
 
Crystallization of the SmgGDS-RhoA complex 
In order to better understand the molecular mechanism by which SmgGDS activates 
RhoA, we set out to crystallize a complex of SmgGDS bound to nucleotide-free RhoA.  We 
used bioinformatics-based methods to guide construction of several SmgGDS truncation 
mutants (Fig. 35).  The exchange activities of these truncation mutants were also assessed 
using full-length RhoA as a substrate GTPase.  Subsequently, we observed that some N-
terminal truncation constructs displayed reduced exchange activity (Fig. 36).  Therefore, we 
used a limited proteolysis of the various mutants in order to determine whether truncation of 
N- or C-terminus reduces the stability of SmgGDS (Fig. 37).  Interestingly, N-terminal 
truncations were more readily cleaved by trypsin than full-length or C-terminal truncation 
mutants.   
The human SmgGDS gene encodes a long and a short isoform which differ by the 
insertion of a single ARM repeat between ARM-2 and ARM-3 of bovine SmgGDS (Fig. 27).  
The functional significance of this splice variant is not known.  Our studies conducted above 
utilized a short isoform lacking ARM-2A; therefore, we generated the long isoform of 
SmgGDS to determine whether the presence of ARM-2A significantly affects the exchange 
activity of SmgGDS upon full-length RhoA.  Human SmgGDS, representing the long 
isoform, exhibited an exchange activity comparable to that of the short isoform used above 
 98
(data not shown).  Moreover, human SmgGDS bound nucleotide-free RhoA similarly.  
Therefore, we deduced that ARM-2A does not significantly alter the activity of SmgGDS, 
and may be used to functionally substitute bovine SmgGDS during our screening for 
conditions that promote crystallization. 
Based on the above findings, we used size-exclusion chromatography to isolate a 
dimeric complex consisting of nucleotide-free full-length RhoA bound to: (1) full-length 
bovine SmgGDS, (2) full-length human SmgGDS, or (3) C-terminal truncations of bovine 
SmgGDS.  Isolated protein complexes were concentrated to ~15-25 mg/ml and subsequently 
determined to be highly pure and of apparent 1:1 molar ratio as determined by SDS-PAGE 
analysis.  These protein complexes were then used to screen numerous conditions for the 
formation of protein crystals using the sitting drop vapor diffusion method at both 4°C and 
18°C.  While no defined crystals developed for any of these outlined conditions, we observed 
non-amorphous precipitate that resembled spherulites at 18°C for two crystallization 
conditions utilizing one particular SmgGDS truncation mutant bound to RhoA.  SmgGDS (1-
472) bound to RhoA formed unique non-amorphous precipitate in: (a) 100 mM HEPES pH 
7.5, 200 mM CaCl2, 28% (v/v) PEG 400, and (b) 100 mM HEPES pH 7.5, 200 mM MgCl2, 
30% (v/v) PEG 400.  These conditions were subsequently optimized, resulting in the 
formation of protein crystals in the form of small needles, needle clusters, plates, and single 
triangular crystals in a several conditions (Fig. 38).  To date, these protein crystals remain too 
small for X-ray diffraction and optimization of conditions necessary to increase crystal size 
are currently underway.   
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Discussion 
Here we report the first detailed in vitro biochemical analysis of GTPase substrate 
specificities for the ARM repeat-containing protein SmgGDS using robust real-time 
methodologies.  Contrary to numerous previous reports, which mischaracterized SmgGDS as 
a non-specific GEF, SmgGDS selectively engages a subset of Rho GTPases and 
demonstrates guanine nucleotide exchange activity toward Rho isozymes.  In particular, we 
have demonstrated exchange activity upon the GTPase substrates RhoA and to a lesser extent 
RhoB.  This finding is in agreement with several previous reports that suggest RhoA is the 
preferred GTPase substrate for SmgGDS [174, 179, 189, 190, 192, 193, 201, 202, 206].   
Interestingly, this exchange activity required the C-terminal PBR of the Rho.  This 
was an unexpected finding, given that the crystal structures of several Dbl-family GEFs [49, 
57-60] and atypical exchange factor SopE [153] bound to nucleotide-free GTPases reveal 
that the C-terminal region of the bound GTPase does not contribute the binding interface.  
Therefore, we hypothesize that SmgGDS interacts with Rho GTPases via a novel mechanism 
(Fig. 39), which suggests that SmgGDS may play signaling roles other than merely serving 
as an exchange factor for Rho isozymes.   
This notion is further substantiated by the seemingly paradoxical finding that Rac1 
binds to SmgGDS preferentially in the nucleotide-free state, yet is not directly activated by 
SmgGDS in vitro.  Again, this interaction with SmgGDS is mediated by the C-terminal 
polybasic region of Rac1.  Supporting our findings and the idea that SmgGDS may play 
additional signaling roles are the recent studies by the Lanning et al., which indicate that 
SmgGDS engages RhoA and Rac1 preferentially in the nucleotide-free state and that the C-
terminal polybasic region is critical for this interaction [202, 203, 206].  Moreover, they 
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demonstrate that SmgGDS shuttles with Rac1 into the nucleus dependent upon a nuclear 
localization signal within Rac1 and that nucleotide-free RhoA prevents SmgGDS from 
entering the nucleus.  These observations, coupled with the finding that SmgGDS contains a 
functional nuclear export signal responsible for shuttling it out of the nucleus are strong 
indicators that SmgGDS may play additional signaling roles previously unappreciated.  
SmgGDS requires a much higher concentration to elicit the exchange activity 
comparable to Dbl family GEFs, such as Dbs.  This indicates to us that SmgGDS is either an 
inefficient GEF or that SmgGDS requires a yet unidentified accessory protein in order to 
elicit full exchange activity.  Alternatively, SmgGDS may exist in an auto-inhibited state that 
is activated upon binding a stimulatory protein or via a phosphorylation event, although no 
evidence exists to support this notion.  The requirement of a binding partner to fully activate 
the exchange activity of atypical GEFs is well characterized for the CZH family proteins 
related to Dock180.  Dock180 binds to ELMO and forms an obligate heterodimer, which 
together function to activate Rac1.  SmgGDS may require a binding partner in a similar 
fashion to efficiently engage the Rho isoforms or perhaps other Rho GTPases.  Potential 
candidate binding partners include the ARM repeat-containing protein SMAP/KAP3 [196, 
197] and the GB domain of β-Pix [200].  Ongoing studies in our group are aimed at 
determining whether these and other proteins can directly modulate the exchange activity of 
SmgGDS.  We are currently using a co-immunoprecipitation assay in cells to pull out 
binding partners for SmgGDS and using mass spectrometry to identify novel proteins.  
However, we can not completely rule out the possibility that our observed guanine nucleotide 
exchange, which required an excessive amount of SmgGDS, may be a secondary 
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consequence to a previously unappreciated role for SmgGDS.  Further experiments will shed 
light on this prospect.  
In order to gain insight into the molecular mechanism by which SmgGDS engages 
nucleotide-free GTPases, we sought to co-crystallize a complex of SmgGDS bound to 
nucleotide-free RhoA for use in structure determination.  Numerous truncation mutants of 
bovine SmgGDS, as well as the full-length bovine short isoform and the full-length human 
long isoform were used to form a heterodimeric complex with full-length nucleotide-free 
RhoA.  After screening numerous crystallization conditions, we identified a set of conditions 
that promote the crystallization of one particular SmgGDS truncation mutant (1-472) bound 
to RhoA.  This promising result is the first step to better understanding the molecular 
mechanism by which SmgGDS catalyzes guanine nucleotide exchange upon Rho and will 
additionally shed light on the elusive cellular roles of SmgGDS.  Extensive optimization of 
these protein crystals is currently underway.   
Future studies will explore the molecular mechanism by which SmgGDS engages 
Rac1.  We are able to isolate a dimeric complex of nucleotide-free Rac1 bound to SmgGDS 
and may use this complex as a crystallization target to understand why SmgGDS binds to 
both RhoA and Rac1 preferentially in the nucleotide-free state, yet only exchanges 
nucleotide upon RhoA.  Other potential crystallographic targets of SmgGDS include binding 
a peptide comprising the C-terminal polybasic region of Rac1 and RhoA to understand the 
specificity determinants of binding to the PBR of small GTPases.  The Rac1 PBR contains an 
NLS motif while the RhoA PBR does not.  The mechanism by which SmgGDS differentially 
engages these two peptides may also explain why SmgGDS is a GEF for RhoA and not 
Rac1.   Interestingly, SmgGDS contains a canonical sequence utilized by Importin-α to 
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engage the NLS motifs.  Future experiments may investigate the role that this binding motif 
plays in catalyzing guanine nucleotide exchange and/or engaging nucleotide-free Rac1.   
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Figure 27: Sequence analysis of SmgGDS. 
A multiple sequence alignment for SmgGDS was generated from several different species and used to calculate the percent identity for each 
residue of SmgGDS; these values are depicted as a bar graph. Also shown is the predicted secondary structure: red cylinders, α-helix; black line, 
unstructured. The regions encompassing the armadillo (ARM) repeats are depicted at top as blue segments. Note the lack of conservation within 
the vicinity of ARM-2A is due to the presence of a short isoform of SmgGDS, which lacks ARM-2A.  
 104
 
 
 
 
 
 
 
 
 
 
 
Figure 28: Previously published SmgGDS target GTPase substrates. 
A multiple sequence alignment of several Ras and Rho GTPases was used to construct a phylogenetic 
tree. Highlighted in blue* are the GTPases which SmgGDS is reported to activate; note these 
GTPases are highly unrelated.   
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Figure 29: Conservation of SmgGDS among numerous species. 
Multiple rounds of sequence similarity searches were used to compile a list of SmgGDS orthologs for 
a diverse array of species. A multiple sequence alignment of these SmgGDS orthologs was then used 
to construct a phylogenetic tree representing the conservation of SmgGDS among various species. 
Major groupings for each species are also illustrated.  
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Figure 30: SmgGDS is a GEF for select Rho isozymes, dependent upon the C-terminal polybasic region. 
(A-E) 2 µM of the indicated Rho isozyme, full-length (A-C) or C-terminal truncation (D-E) was allowed to equilibrate in the presence of 500 nM 
Bod-GTP; at time indicated by arrow, 10 µM of full-length bovine SmgGDS was added to initiate the exchange reaction, as described in 
experimental procedures. Insets depict positive controls using 500 nM Dbs. Note SmgGDS displays robust activation of (A) full-length RhoA and 
(B) full-length RhoB. C-terminal truncation of the polybasic region (∆PBR) diminishes exchange activity toward (D) RhoA (∆PBR) and (E) RhoB 
(∆PBR).  
 107
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 31: SmgGDS is not a GEF for Rac isozymes, Cdc42-related GTPases, or Ras-related 
GTPases. 
(A-C) 2 µM of the indicated Ras or Rho GTPase was allowed to equilibrate in the presence of 500 
nM Bod-GTP; at time indicated by arrow, 20-40 µM of full-length bovine SmgGDS was added to 
initiate the exchange reaction, as described in experimental procedures. Also depicted are positive 
controls in black dashed line. Note that the rate of guanine nucleotide exchange before addition of 
SmgGDS is identical to the rate of guanine nucleotide exchange after the addition of SmgGDS, 
indicating that SmgGDS is not a GEF for (A) Rac isozymes, (B) Cdc42-related GTPases, or (C) Ras-
related GTPases. 
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Figure 32: SmgGDS preferentially binds nucleotide-free RhoA via the C-terminal polybasic 
region. 
Analytical size-exclusion chromatography was used to determine the binding selectivity of SmgGDS 
for the various guanine nucleotide-bound states of RhoA. SmgGDS was incubated with RhoA at a 1:2 
molar ratio and analyzed for complex formation, as described in experimental procedures. SmgGDS 
forms a stable complex with nucleotide-free full-length (FL) RhoA, but not with GDP- or GTPγS-
bound RhoA (FL).  Additionally, truncation of the C-terminal PBR (∆PBR) reduces the capacity for 
SmgGDS to bind nucleotide-free RhoA (bottom panel). 
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Figure 33: SmgGDS preferentially binds nucleotide-free Rac1 via the C-terminal polybasic 
region. 
Analytical size-exclusion chromatography was used to determine the binding selectivity of SmgGDS 
for Rac1. SmgGDS was incubated with nucleotide-free full-length Rac1 (FL) or Rac1 lacking the C-
terminal polybasic region (∆PBR) at a 1:2 molar ratio and analyzed for complex formation (left 
panel). SmgGDS was also incubated with GDP-bound Rac1 (FL) and analyzed for complex 
formation (right panel). SmgGDS forms a stable complex with nucleotide-free, but not GDP-bound 
Rac1 (FL); deletion of the PBR greatly reduces the binding affinity. 
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Figure 34: Rho GTPase binding specificity of SmgGDS. 
Analytical size-exclusion chromatography was used to determine whether SmgGDS binds to the 
nucleotide-free state of several indicated Rho GTPases. SmgGDS was incubated with the indicated 
GTPase at a 1:2 molar ratio and analyzed for complex formation, as described in experimental 
procedures. SmgGDS forms a stable complex with nucleotide-free, RhoB (right panel), but not 
nucleotide-free RhoC or Cdc42 (left panel).  
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Figure 35: Design of construct borders for bovine SmgGDS crystallization. 
Schematic representation of the domain architecture of bovine SmgGDS with predicted secondary structure also depicted. Construct borders were 
designed to remove largely unstructured regions in the C-terminus or non-conserved regions near the N-terminus. Recombinant proteins were 
generated for all constructs, tested for guanine nucleotide exchange activity, and screened for conditions that promote crystallization. The 
construct highlighted at top (residues 1-472) was subsequently determined to be a tractable crystallization target. 
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Figure 36: Guanine nucleotide exchange activity of SmgGDS truncation mutants. 
2 µM of RhoA (FL) was allowed to equilibrate in the presence of 500 nM Bod-GTP; at time indicated 
by arrow 10 µM of the indicated bovine SmgGDS clone was added to initiate the exchange reaction, 
as described in experimental procedures. Highlighted in red is the activity of the SmgGDS construct 
used for crystallization with nucleotide-free RhoA, also note that N-terminal truncation reduces the 
exchange activity of SmgGDS.  
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Figure 37: Limited proteolysis of SmgGDS truncation mutants. 
Purified samples of bovine SmgGDS truncation mutants were subjected to limited proteolysis with 
trypsin, then analyzed by SDS-PAGE and stained with Coomassie blue, as described in experimental 
procedures. N-terminal truncations, such as 19-494, 19-472, 75-494, and 75-472, all result in 
susceptibility to trypsin digestion. However, full-length (FL) and the C-terminal truncation 1-494 
were largely resistant to trypsin-mediated digestion, suggesting that the N-terminus is necessary for 
protein integrity.   
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Figure 38: Crystallization of SmgGDS bound to nucleotide-free RhoA. 
A complex of SmgGDS (residues 1-472) bound to full-length, nucleotide-free RhoA was isolated 
using size-exclusion chromatography, as described in experimental procedures, and concentrated to 
~15 mg/ml for crystallization. Purified protein complex was added to well solution at a 1:1 ratio in 
sitting drop vapor diffusion crystallization trays. Crystallization conditions for (A) consisted of 100 
mM Tris HCl pH 7.5, 20% (v/v) Jeffamine M600, 200 mM CaCl2, while crystallization conditions for 
(B) consisted of 100 mM HEPES pH 7.5, 25% (v/v) PEG 400, 200 mM MgCl2. Protein crystals 
formed within two days of setting up conditions. 
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Figure 39: Model for the engagement of Rho GTPases by SmgGDS. 
A structural homology model of bovine SmgGDS (left panel) was generated using 3D-PSSM with 
Importin-α (right panel) as the template structure. Highlighted in green are the canonical nuclear 
localization sequence (NLS)-binding motifs of SmgGDS and Importin-α, which is shown bound to an 
NLS peptide. RhoA is also depicted to scale to demonstrate how SmgGDS may engage target GTPase 
substrates and directly interact with the NLS of certain GTPases, such as Rac1.  
 
 
 
 CHAPTER 4: CONCLUSIONS AND FUTURE DIRECTIONS 
Physiological implications of Gαq-p63RhoGEF-RhoA signaling 
Numerous studies suggest a physiologically important role for Gαq-mediated 
activation of RhoA.  In light of our above findings regarding the direct activation of 
p63RhoGEF by Gαq, these physiological studies take on a whole new meaning.  Primarily, 
our results suggest that p63RhoGEF or the closely related paralogs Trio and Kalirin may be 
the key mediators of numerous signaling pathways mediated by Gαq/RhoA signaling.   
Interestingly, many studies which suggest an important physiological role for Gαq-
RhoA signaling do not investigate how Gαq is mediating RhoA activation.  Instead these 
studies were conducted in the context of a particular signaling pathway of interest to that 
particular research group, for example, β-arrestin signaling [107], NADPH oxidase system 
[100], cyclooxygenase-2 regulation [142], cell survival and apoptosis[123, 124], Pasteurella 
mulocida toxin [247-249], MAP kinase cascades [250].  In many of these studies the authors 
suggest that the p115 family of RGS-containing RhoGEFs lie downstream of Gαq.  However, 
data does not support this model [128, 137-139, 145].   
The most compelling physiological evidence supporting a biological role of Gαq/11-
RhoA signaling stems from cardiac hypertrophy and hypertension model systems [227, 228, 
251].  Heart muscle cells are terminally differentiated, but can increase in cell size in 
response to various growth-promoting signals resulting in pathological cardiac hypertrophy.  
Stimulation of Gαq-coupled GPCRs results in a characteristic hypertrophic response in 
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cardiomyocytes and genetic studies in mice have implicated Gαq/11 as direct mediators of 
cardiac hypertrophy [252].  In cultured neonatal mouse cardiomyocytes, this hypertrophic 
response can be characterized by the enhanced expression of several genes including c-fos, 
atrial natriuretic peptide (ANF), and MLC-2 and by the organization of sarcomeric-localized 
proteins.  Most importantly, many of these phenotypic responses associated with cardiac 
hypertrophy are dependent upon Gαq-mediated activation of RhoA [99-106].   
In these cases, extracellular stimulation of Gαq-coupled GPCRs promotes Gαq-
mediated RhoA activation, resulting in a characteristic cardiac hypertrophic response.  
Interestingly, transgenic mice over-expressing RhoA specifically in the heart had severe 
cardiac dysfunction, further implicating RhoA in heart disease [253].  Collectively, these 
studies, coupled with the fascinating finding that p63RhoGEF is highly expressed in the heart 
[146-148] and in fact differently localized to sarcomeric sub-structures within the 
myocaridium [147], strongly suggest that p63RhoGEF is a previously unappreciated 
signaling node which regulates cardiac hypertrophy.   
An additional pathway which may be regulated by Gαq-responsive Dbl family GEFs, 
such as p63RhoGEF, Trio, and Kalirin is the renin-angiotensin system.  The renin-
angiotensin system is a key regulator of blood pressure in a wide variety of vascular smooth 
muscle cells and is dependent upon RhoA activation.  Furthermore, deregulated angiotensin 
signaling is implicated in a number of heart-related pathologies including hypertension, heart 
failure, and cardiac hypertrophy [254].  Recent studies have implicated Gαq/11-RhoA 
signaling pathways as critical mediators of angiotensin II-driven changes in cell morphology 
[107].  Additionally, several studies have shown that prolonged administration of angiotensin 
II in mice results in cardiac hypertrophy in a Rho-dependent manner [99, 100].  This suggests 
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the intriguing possibly that this response is mediated by signaling through p63RhoGEF or 
related paralogs.  
Additional studies implicate Gαq-RhoA signaling cascades as critical regulators of 
vascular smooth muscle contraction and Ca2+ sensitization [255], further suggesting an 
important role in the heart for p63RhoGEF.  The second messenger Ca2+ is an important 
mediator of contraction in both highly organized cardiac and skeletal muscle as well as 
disorganized smooth muscle.  Muscle contraction is mediated by repeated cycles of actin-
myosin cross-bridging in the presence of Ca2+.  For decades, researchers have studied a Ca2+-
dependent response.  However, more recently Ca2+-independent pathways have been 
uncovered that utilize RhoA to regulate the contractility of vascular smooth muscle [255].  
Contractility is enhanced by GPCR-mediated activation of RhoA in vasculature independent 
of intracellular Ca2+; this is termed Ca2+ sensitization.  Of significant importance, many Gαq-
coupled GPCRs are well characterized for their ability to mediate the Rho-dependent Ca2+ 
sensitization response in vascular smooth muscle [108-111], presumably via p63RhoGEF-
mediated mechanisms. 
In the near future our group will work to better understand the cellular role of 
p63RhoGEF.  We will use siRNA techniques in order to implicate p63RhoGEF as the major 
signaling nexus which links Gαq-coupled GPCRs to the downstream activation of RhoA.  
Many model systems are appropriate and tractable for this in vivo characterization of 
p63RhoGEF.  However, perhaps the most relevant is the above mention cardiac hypertrophy 
model where Gαq relies on RhoA to elicit distinct physiological events, such as the induction 
of the c-fos, ANF, and MLC-2 genes [99-106].  Alternatively, HEK-293 cells stably 
expressing the AngIIAT1AR have been shown to activate RhoA in response to angiotensin II 
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treatment in a Gαq/11-dependent manner [107].  We will use siRNA to reduce endogenous 
levels of p63RhoGEF and determine whether angiotensin II-mediated activation of RhoA is 
negatively impacted.  An additional cellular system may utilize previously described 
Gα12/13-deficient MEFs, which activate RhoA downstream of LPA, bombesin, and 
endothelin in a Gαq/11-dependent manner [139].  We may reduce endogenous p63RhoGEF 
using siRNA methods and determine the capacity for these ligands to signal downstream to 
RhoA. 
 
Determining target substrate specificity of exchange factors 
Exchange factors regulate distinct signaling pathways and display specificity within a 
single subfamily.  Yet, SmgGDS has consistently been reported to activate numerous non-
related Ras superfamily GTPases.  Moreover, these studies of SmgGDS typically contradict 
one another, even within the same research group.  Unfortunately, the mischaracterization of 
exchange factors, such as SmgGDS, occurs alarmingly frequently.  This is evidenced by 
p63RhoGEF, which was mischaracterized as a Rac1/Cdc42 exchange factor, and even named 
the gene RAC/CDC42 EXCHANGE FACTOR, when it is clearly a Rho-specific GEF.   
The major culprit for such discrepancies in the literature is the use of methodologies 
that rely on the discontinuous monitoring of guanine nucleotide exchange and do not control 
for the spontaneous exchange rate elicited by all G proteins.  Fortunately, recent advances 
have allowed the use of fluorescence-based real-time assays, such as those employed by the 
above described study of p63RhoGEF and SmgGDS, to supersede these more traditional 
radioactive-based assays. 
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